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Resumo 
 
A doença de Alzheimer (DA) é o tipo mais comum de demência no mundo. É 
caracterizada molecularmente pela deposição extracelular de placas senis (PS) 
compostas por agregados do péptido amiloide beta (Aβ), pela formação de 
emaranhados neurofibrilares (EN) derivados da hiperfosforilação da proteína 
Tau, pela disfunção sináptica devido aos depósitos de PS e EN e também pelo 
stress oxidativo induzido pelo enfraquecimento das vias metabólicas.  
A via de sinalização da insulina desempenha um papel principal em diversas 
vias da DA, tal como na clivagem da APP, hiperfosforilação da proteína Tau, 
eficiência da sinalização da insulina influenciada pela Apolipoproteína E (ApoE) 
e pela enzima envolvida na degradação de insulina que também é a enzima 
principal na degradação de Aβ. 
Crescente evidência relaciona a DA com a diabetes de tipo 2 (T2D) devido ao 
mau funcionamento da sinalização pela insulina e da resistência cerebral à 
mesma. Num estudo baseado num cohort da região de Aveiro, foi observada 
uma correlação entre a diabetes e um mau resultado no teste do ‘Mini Mental 
State Examination’. Adicionalmente, também foi observada uma correlação 
entre os portadores do alelo ApoE-ɛ2 e um estado protetor contra a T2D. Este 
alelo também foi observado na literatura como sendo protetor contra a DA.  
Posteriormente, uma análise de interações entre proteínas, identificou várias 
proteínas envolvidas tanto na DA como na sinalização da insulina. 
Correlacionando estes dados com o proteoma da sinapse, foi possível observar 
que existe uma grande representação das duas condições e também das 
proteínas coincidentes às duas (88% para a DA, 79% para a sinalização da 
insulina e 96% para as proteínas relacionadas com ambas), reforçando o papel 
de ambas as vias na sinalização e plasticidade sináptica. Do estudo de ontologia 
genética para a DA, foi possível identificar diversas vias importantes, tais como, 
resposta a um estímulo, organização de componentes celulares, comunicação 
celular, ligação proteica e ligação a uma cinase. Em relação à sinalização da 
insulina, as mesmas categorias apareciam com maior representação, 
significando que a insulina tem um papel importante em muitos eventos da DA.  
Por fim, o tratamento de SH-SY5Y diferenciadas com 0, 1, 10 e 100 nM de 
insulina por 0, 10 e 60 minutos mostraram uma diminuição nos níveis 
intracelulares da proteína Tau e um aumento na sua fosforilação na serina 396. 
Em relação à proteína percursora amiloide (APP), o tratamento de insulina levou 
a um aumento nos níveis intracelulares, quando exposta por 10 minutos seguido 
por uma diminuição aos 60 minutos. Quanto à fosforilação da treonina 668 da 
APP, foi previamente demonstrado que um aumento na fosforilação desse 
resíduo, promove a clivagem pela via amiloidogénica, levando à produção de 
Aβ. Nas células tratadas com insulina, um aumento claro da fosforilação desse 
resíduo da APP foi observado aos 10 minutos. Aos 60 minutos, os níveis da 
fosforilação eram baixos provavelmente devido aos baixos níveis de APP total.   
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Abstract 
 
Alzheimer’s disease (AD) is the most common type of dementia worldwide. It is 
molecularly characterized by deposition of extracellular senile plaques (SPs) 
composed by aggregated amyloid beta (Aβ) peptide, the formation of 
neurofibrillary tangles (NFTs) derived from hyperphosphorylation of the 
microtubule-associated protein Tau, synaptic dysfunction due to the deposits of 
SPs and NFTs and oxidative stress induced by impaired metabolic pathways.  
The insulin signalling pathway can play a major role in diverse AD related 
pathways, such as APP cleavage, Tau hyperphosphorylation, Apolipoprotein E 
(ApoE) influence in insulin signalling efficiency and the insulin degrading 
enzyme, which is also the major Aβ degrading enzyme.  
Growing evidence links AD with type 2 diabetes (T2D) due to impaired insulin 
signalling (IS) and brain insulin resistance. In a cohort based study in the Aveiro 
region, a correlation between diabetes and poor cognitive scores in the Mini 
Mental State Examination (MMSE) test were observed, with a p-value of 0.072. 
Additionally, carriers of the allele ApoE-ɛ2 appeared to be protective against 
diabetes, in the literature the same allele appears to be protective for AD. 
Posteriorly, the analysis of protein interactions, via the development of 
interactome networks, identified several proteins involved in both AD and the IS 
pathways. Also, by correlating these pathways with the synapse proteome, a 
very high overlap was observed (88% for AD, 79% for IS and 96% for AD and IS 
coincident proteins), enforcing the importance of both pathways in synaptic 
signalling and plasticity. From gene ontology studies, it was possible to assess 
the principal biological processes and molecular functions of the dataset of 
proteins. For AD, response to stimulus, cellular component organization, cell 
communication, signalling, protein binding, receptor binding and kinase binding 
were categories with elevated representation. Regarding coincident proteins 
between AD and IS pathways, an increase in all categories was observed, 
meaning that insulin plays a pivotal role in many AD events.  
Finally, the analysis of SH-SY5Y differentiated cells treated with 0, 1, 10 and 100 
nM of insulin for 0, 10 and 60 minutes, showed a decrease on the intracellular 
total levels of protein Tau and an increase in the phosphorylation at serine 396. 
Regarding the amyloid precursor protein (APP), increases in intracellular levels 
were observed, when treated with insulin for 10 minutes, followed by a decrease 
for 60 minutes exposure. The phosphorylation of APP at threonine 668, has 
previously been related to increased production of Aβ, by promoting APP 
cleavage via the amyloidogenic pathway. In cells treated with insulin, a clear 
increase was detected at the 10-minute time point. At 60 minutes, the levels of 
phosphorylation were low probably due to low total APP levels.   
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1. Introduction         
1.1. Characterizing Alzheimer’s disease 
Alzheimer’s disease (AD) is the most common type of dementia worldwide. It is estimated by the 
World Alzheimer Report of 2015 that 46.8 million people suffer from dementia and that this 
number will duplicate every 20 years.1 
AD is a progressive disease characterized by a deterioration of memory and cognitive functions that 
can lead to death in 3 to 9 years after diagnosis.2 In early stages of the disease, almost no symptoms 
occur, but in late-stages, there is complete loss of autonomy and no response to the environment. 
No cure is available for AD or other type of dementia, although some drugs can delay disease 
progression.3 
Brain changes in AD can begin many years before symptom onset, but there is no efficient early 
diagnosis. Nevertheless, some possible risk factors have been described such as age, the presence 
of certain alleles of genes (particularly apolipoprotein E – ApoE-ε4)45, gender (female)6, low 
education levels7, head trauma8, small hippocampal volume6, insulin resistance9, high cholesterol, 
hypertension, reduced exercise and obesity5. 
The molecular mechanisms of the disease have been studied for many years and principal hallmarks 
have been well described. Amongst them the accumulation of extracellular senile plaques (SPs) 
caused by the deposition and aggregation of the peptide amyloid β (Aβ) which arises as a result of 
amyloid precursor protein (APP) cleavage10,11; the formation of neurofibrillary tangles (NFTs) 
derived from hyperphosphorylation of the microtubule-associated protein Tau12,13 ; synaptic 
dysfunction due to the deposits of SPs and NFTs and the oxidative stress induced by impaired 
metabolic pathways14. 
 
 
1.1.1. Amyloid precursor protein cleavage and amyloid β production 
 
 The amyloid precursor protein (APP) is a transmembrane protein found in many tissues, 
and is targeted to the synapses of neurons. The precise function of APP is unknown, but some 
assumptions are possible. Mice with deficient APP show many phenotypes including reduced body 
and brain size, impaired learning and long-term potentiation (LTP) and hypersensitivity to 
seizures15. Thus it would appear that APP has an important role in memory associated events. At a 
cellular level, studies employing wild-type APP overexpression in transfected cell lines showed 
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improved cell growth, motility, neurite outgrowth and cell survival16. Thus APP, and APP derived 
fragments have been attributed with growth factor related characteristics. 
 APP processing is achieved by cleavage at specific sites and performed by specific 
proteolytic enzymes. APP can be cleaved by two different pathways, the amyloidogenic pathway 
and the non-amyloidogenic pathway. In the non-amyloidogenic pathway, APP is cleaved by α and 
γ-secretase, originating sAPPα and the peptides P3 and AICD (Figure 1). P3 is not toxic to the 
neurons and can be rapidly degraded17. On the other hand, in the amyloidogenic pathway, APP is 
cleaved by β and γ-secretase, originating sAPPβ and the peptides Aβ and AICD. The excess of Aβ, 
which aggregates as SPs, is one of the major contributors to the degeneration and dysfunction of 
neurons in AD18. 
 
 
 
 
Figure 1-- APP cleavage via the amyloidogenic and non-amyloidogenic pathway. Secreted products obtained in the two 
pathways are indicated. Taken from: 19 
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1.1.2. Hyperphosphorylation of microtubule-associated protein Tau 
 
 
 The protein Tau is expressed abundantly in the axons of neurons in the central nervous 
system, but can also be found in many others cells. This protein’s most important role is to promote 
stability and assembly of microtubules, although this function can be complemented by other 
proteins, especially microtubule-associated protein 1B (MAP1B)20, suggesting that Tau protein is 
not vital. Indeed, Tau knockout mice are viable, fertile, normal and show no signs of 
neurodegeneration. Complementing, knock out of Tau by small interfering RNA in primary neurons 
did not cause death, nor did it prevent axon formation and growth21.  
 In AD, abnormal Tau phosphorylation and aggregation plays an important role in 
pathogenesis, forming intracellular neurofibrillary tangles (NFTs) that lead ultimately to cell death22. 
In the hyperphosphorylated state, Tau sequesters normal Tau and other proteins associated to 
microtubules, leading to microtubule destabilization and polymerization. Consequentially, axonal 
transport and neurotransmission are compromised, affecting cognitive functions. The major group 
of proteins involved in Tau phosphorylation are the proline-directed protein kinases (PDPK) that 
include glycogen synthase kinase 3 (GSK3), mitogen activated protein kinase (MAPK), Tau-tubulin 
kinase, cyclin-dependent kinase (principally CDK2 and CDK5) and stress-activated protein kinases 
(SAP kinases). In Tau extracted from AD patient brains, 45 phosphorylation sites (Figure 2) were 
discovered (29 serines (S), 13 threonines (T) and 3 tyrosines (Y)), of which, the majority can be 
phosphorylated by GSK3β, making this kinase, one of the most relevant in Tau 
hyperphosphorylation13,23.  
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Figure 2- Tau phosphorylation sites and responsible kinases retrieved from AD brains. S- Serine, T- Threonine and Y- 
Tyrosine. Microtubule – binding domain is indicated ***. Taken from:13 
 
 
 
1.2. Insulin signalling pathway 
 
 Insulin controls extensive biological processes by acting on a tyrosine kinase receptor. 
Receptor activation initiates a cascade of events involving phosphorylation, leading to activation or 
inactivation of many enzymes that control many physiological functions, namely metabolism and 
growth. Perturbations in the cascades can lead to insulin resistance24.  
 Insulin’s main actions are to stimulate the uptake of glucose and glycogen synthesis but it 
is also able to regulate many biological processes such as increased amino acid uptake, increased 
lipid synthesis, and decreased lipolysis, among others depending on the type of cells25.  
 Many proteins are phosphorylated and dephosphorylated in the cascade of events when 
insulin binds to its receptor. Insulin and insulin receptor (IR) binding, results in a conformational 
change that induces the autophosphorylation of many tyrosine residues in the receptor26. The 
insulin receptor substrate family (IRS) recognizes these residues, which are, in turn, recognized by 
the phosphoinositide 3-kinase (PI3K). PI3K has the ability to phosphorylate phosphatidylinositol 4,5-
bisphosphate (PIP2) into phosphatidylinositol (3,4,5)-trisphosphate (PIP3) and in the presence of 
phosphoinositide-dependent kinase-1 leads to the phosphorylation and activation of protein kinase 
B (PKB, also known as AKT). The activation of AKT is necessary for the regulation of many processes, 
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such as recruitment of Glucose transporter type 4 (GLUT4) to the membrane for glucose entrance, 
inhibition of GSK3α and β, resulting in glycogen synthesis and activation of the mammalian target 
of rapamycin (mTOR), which promotes protein synthesis27(Figure 3). The binding of insulin to the 
IR, also triggers a second pathway, that leads to growth factor receptor-bound protein 2 (GRB2) 
activation, which in turn associates with the guanine nucleotide exchange factor son-of sevenless 
(SOS) leading to the activation of the mitogen-activated protein kinases (MAPK) pathway28. The 
activation of the MAPK pathway promotes cell division and differentiation.  
 It has only been a few years since the brain was considered as an insulin-sensitive organ. 
This was achieved by the detection of insulin and insulin receptors in the brain, although the origin 
of the insulin is still in debate. Its origin has been explained as deriving from peripheral or central 
sources, or even both. The discovery of insulin mRNA in the brain proved that it could be produced 
in the brain29,30. On the other hand, it was also shown that insulin can cross the blood-brain barrier 
(BBB) using a receptor mediated transport system29–31. Recent studies demonstrated that insulin 
regulates brain glucose and lipid metabolism, but it also regulates neuronal activities and 
development, playing an important role in learning and memory30. 
 
 
 
Figure 3- Different actions of insulin when bound to the receptor. Adapted from: 32 
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1.3. Type 2 diabetes mellitus 
 
 Type 2 diabetes mellitus (T2D) is a metabolic disorder that is characterized mainly by an 
elevation of glucose in the blood due to insulin resistance. This disease accounts for 90% of all cases 
of diabetes and is in exponential growth, as of 2014 records show that 422 million adults worldwide 
have T2D in comparison with only 108 million in 1980. Some people may be genetically predisposed 
to contract T2D33, however this disease occurs mainly as a result of obesity and lack of exercise34. 
This condition is mainly controlled with the administration of metformin, leading to a decrease in 
glucose production by the liver and an increase in insulin sensitivity of body tissues35. 
 Many factors can molecularly lead to insulin resistance. The most common include a 
decrease in the number of insulin receptors and of their catalytic activity, an increased Ser/Thr 
phosphorylation of the IR or the IRS, increase in tyrosine phosphatase activity, a decrease in PI3K 
and Akt kinase’s activities and defective GLUT4 expression and/or function.  These molecular 
changes lead to defective metabolism and a defective insulin cascade of events36.  
 
 
 
 
1.4. Insulin signalling pathway and Alzheimer’s disease 
 
 In 1970 S. Hoyer reported reduced glucose levels and lower cerebral metabolic rates in the 
brains of demented individuals37. Today we know that many pathologies exhibit diminished brain 
glucose absorption, among them AD, Parkinson's disease, Multiple sclerosis, Huntington's Disease, 
Duchenne muscular dystrophy, forms of Autism, Down’s Syndrome and Type I and Type II Diabetes 
Mellitus. The risk of developing AD is 50-60% greater in individuals with T2D38. Consistently, rats 
injected with streptozotocin intracerebroventricularly exhibit decreased glucose/energy brain 
metabolism and learning and memory deficits39. 
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1.4.1.  Insulin influence on APP cleavage 
 
 
 APP is one of the main proteins associated with AD. It is not known how the cell determines 
the pathways via which APP is processed. However insulin can play a major role in APP processing, 
promoting the non-amyloidogenic pathway. In a recent study, it was demonstrated that in the SH-
SY5Y cell line insulin increased the levels of ADAM10 (α-secretase) and decreased those of BACE1 
(β-secretase), leading to a decrease in Aβ production. Consistently, disturbances in the insulin 
cascade of events can be related with increases in Aβ production40. 
 
 
1.4.2. Tau phosphorylation by GSK3β 
 
 Glycogen synthase kinase-3 β (GSK3β) is a proline-directed serine/threonine kinases, 
expressed ubiquitously and involved in many cellular processes, namely glycogen metabolism41, 
gene transcription42, apoptosis43 and microtubule stability44,45.  
 This kinase is under close regulation of insulin and protein phosphatase 1 (PP1), both with 
the capacity to inactivate it. Phosphorylation of GSK3β at serine 9 by insulin turns the kinase inactive 
while PP1 has de ability to dephosphorylate the tyrosine 216 leading to the same inactive state46.  
 In AD post mortem brain analysis, the values of PP1 appear diminished, leading to an 
increase activation of GSK3β. In the PC12 cell line, the presence of Aβ inhibited PP147, leading to 
hyperphosphorylated protein Tau, probably through dysregulation of GSK3β. 
 In T2D, deregulation in the insulin signalling (IS) pathway can also lead to GSK3β activation. 
Taken together, the deregulation of IS pathway and the inhibition of PP1 lead to a constant 
activation of this protein, continuously phosphorylating its substrates, namely protein Tau. 
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1.4.3.  APOE effect on insulin efficiency 
 
 
 Apolipoprotein E (ApoE), in the brain, can be produced by both glia and neurons and its 
major role is to redistribute lipids among cells in the brain48,49. ApoE has 3 distinctive alleles (ApoE-
ɛ2, ApoE-ɛ3 and ApoE-ɛ4), with ApoE-ɛ4 occurring in more than 50% of AD cases49. 
 Clinical data showed that intranasal administration of insulin improved performance in 
learning and memory of elderly individuals. This performance is also correlated with the plasma 
levels of APP50–52. On the other hand, these effects are ApoE isoform dependent, where ApoE-ɛ4 
carriers showed no improvement in memory tasks or no reduction of APP plasma levels51,53. 
 A recent study in mice showed that insulin signalling impairment in the presence of Aβ was 
specific of ApoE genotype. The expression of ApoE-ɛ4 led to reduced insulin stimulation while ApoE-
ɛ2 and 3 had preventive measures against Aβ, inducing proper insulin signalling54.  
 These results are concurrent with another study that demonstrated that intranasal 
administration of 20 and 40 international units (IU) of insulin improved verbal memory of AD 
subjects, but only for those without the ApoE-ɛ4 allele51. 
 
 
 
1.4.4.  The role of the insulin degrading enzyme (IDE) in AD 
  
 IDE, insulin degrading enzyme, is responsible for degrading insulin, however it is also the 
major enzyme responsible for degrading Aβ. Although IDE is elevated in AD brains, this does not 
translate into a higher Aβ clearance. On the contrary, IDE has more affinity for insulin than Aβ, 
which will lead to a higher degradation of insulin than normal causing a lower glucose metabolism. 
Hence insulin increases extracellular Aβ levels by promoting its secretion, but also by inhibiting its 
degradation via IDE. It is particularly noteworthy that IDE degrades Aβ in both microglial and 
neuronal cultures55,56 and some APP isoforms are common to leucocytes and microglia, the LAPPs. 
Given that insulin resistance arises via a negative feedback loop of the insulin receptor pathway, 
this occurs under conditions of high insulin. The response involves the PI3J/AKT pathway (among 
others) as well as the insulin receptor substrates (IRSs). It is expected that induction of IDE will 
prevent the negative feedback and lower circulating insulin 57,58.  
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 Many other cellular and molecular aspects are common to T2D and AD, these include Ca++ 
mediated signalling, formation of AGE (advanced glycation end-products), Wnt/β-catenin 
signalling, ChaT (ChAT, acetylcholine transferase) and JNK (c-Jun N-terminal kinase) mediated 
responses, these are beyond the scope of this project. It follows that the disease specific 
interactomes will unravel the involvement of several pathways, relevant to AD and T2D. 
 It would appear that a common pathophysiology in T2D and AD is becoming evident. Both 
conditions have a higher incidence with ageing and patients with T2D have a greater risk of 
developing AD. Hyperinsulinaemia and insulin resistance contribute to memory impairment and AD 
is increasingly perceived as also a metabolic disorder. The AD brain loses the capacity to: utilize 
glucose efficiently; respond to critical trophic factor signals and develops resistance to insulin and 
insulin growth factor (IGF). Glucose is the main brain energy source; these anomalies cause the 
brain to ‘starve’ accounting for AD associated abnormalities. Thus the term Type 3 diabetes (T3D) 
has been coined for AD. In closing, individuals with T2D have a higher risk of developing AD, but the 
cellular mechanisms remain unknown. Of concern diabetes medication could increase dementia 
risk. Metformin, prescribed for T2D, increases BACE1 levels and Aβ production, propagating AD 
progression. On a more positive note, insulin in combination with metformin may override the 
BACE1 effect and be beneficial to T2D+AD (T3D) patients59. Thus, it is fundamental to unravel the 
underlying cellular signalling cascades that can contribute to patient management and well-being. 
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2. Objectives of the study 
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2. Objectives 
 
 
 The main goal of this work is to determine if a correlation between Alzheimer’s disease and 
type 2 diabetes at a clinical level, exists. For this purpose, it is necessary to explore different tools 
in order to unravel molecular mechanisms behind the two conditions, such as statistical population 
studies, bioinformatics and also molecular mechanisms. 
 
Thus the specific objectives are to: 
  - Address if there is an association between cognitive capacities and diabetes; 
- Unravel interactome networks relevant to AD and Insulin signalling; 
- Optimize conditions for differentiating a neuronal-like cell line; 
- Determine the effect of insulin on AD relevant molecules. 
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3. Materials and methods 
3.1. Epidemiological observation 
 
 
 A cross-sectional population-based survey was previously carried out on a Portuguese 
population, in the Aveiro district60. Volunteers were admitted, independent of complaints or 
deficits in any cognitive domain. A mandatory inclusion criteria to be 50 years or older was 
observed. Individuals undergoing oncological treatment, diagnosed with psychiatric disorders 
(excluding depression), aphasia, or unable to answer the questions in the structured interview were 
excluded. To ensure generalizability, exclusion criteria were kept to an absolute minimum. 
Participants underwent a semi-structured questionnaire addressing sociodemographic 
characteristics, personal and family history. Subsequently questions typically associated with 
diagnosing dementia were asked. Clinical history and medications taken were collected from clinical 
records and registered. The study group was designated the primary care based cohort, pcb-Cohort. 
 
Figure 4- Workflow for the study design. 
 
 
 Cognitive evaluations and dementia screening tests, irrespective of the clinical diagnosis, 
were performed during the interview. These included Clinical Dementia Rating (CDR)61, Mini 
Mental State Examination (MMSE), Geriatric Depression Scale (GDS)62, Katz of Activities of Daily 
Living (ADL)63 and Instrumental Activities of Daily Living (IADL)64. The tests CDR, MMSE, GDS and 
IADL had been previously standardize for the Portuguese population65. 
Participants were also scored for comorbidities, including diabetes. Volunteers were recruited in 
primary health centers (pcb-Cohort) in the Aveiro region. 
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3.2. Network construction 
The protein networks were built based on protein-protein interactions that are found on the 
available literature, relevant to Alzheimer’s disease (AD) and Insulin signalling (IS) pathways. The 
first step was to determine the key proteins (table 1 and 2) in order to build the interactome for 
each of these proteins. These key proteins were determined using KEGG pathway, for both 
pathways.   
 
Table 1- Alzheimer’s disease pathway key proteins  
Gene name Uniprot code Protein complete name 
APOE 
APP 
BACE1 
MAPT / TAU 
PSEN1 
PSEN2 
ADAM10 
 
ADAM17 
 
APH1A 
 
APH1B 
CAPN1 
CAPN2 
CASP3 
CASP7 
CDK5 
CDK5R1 
IDE 
LPL 
LRP1 
MME/NEP 
NCSTN 
PSENEN 
RTN3 
RTN4 
P02649 
P05067 
P56817 
P10636 
P49768 
P49810 
O14672 
 
P78536 
 
Q96BI3 
 
Q8WW43 
P07384 
P17655 
P42574 
P55210 
Q00535 
Q15078 
P14735 
P06858 
Q07954 
P08473 
Q92542 
Q9NZ42 
O95197 
Q9NQC3 
Apolipoprotein E 
Amyloid beta A4 protein 
Beta-secretase 1 
Microtubule-associated protein tau 
Presenilin-1 
Presenilin-2 
Disintegrin and metalloproteinase domain-containing 
protein 10 
Disintegrin and metalloproteinase domain-containing 
protein 17 
Gamma-secretase subunit APH-1A (Presenilin-
stabilization factor) 
Gamma-secretase subunit APH-1B 
Calpain-1 catalytic subunit 
Calpain-2 catalytic subunit 
Caspase-3 
Caspase-7 
Cyclin-dependent-like kinase 5 
Cyclin-dependent kinase 5 activator 1 
Insulin-degrading enzyme 
Lipoprotein lipase 
Prolow-density lipoprotein receptor-related protein 1 
Neprilysin 
Nicastrin 
Gamma-secretase subunit PEN-2 
Reticulon-3 
Reticulon-4 
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Table 2-Insulin signalling pathway key proteins 
Gene name Uniprot code Protein complete name 
AKT1 
AKT2 
AKT3 
GLUT4/SLC2A4 
 
GRB2 
GSK3A 
GSK3B 
INSR 
IRS1 
IRS2 
MAPK1 
MAPK3 
PIK3CA 
 
PIK3CB 
 
PIK3CD 
 
PIK3R1 
PIK3R2 
PIK3R3 
PDPK1 
SOS1 
SOS2 
HRAS 
KRAS 
NRAS 
ARAF 
RAF1 
BRAF 
MAP2K1 
MAP2K2 
MTOR 
BAD 
FOXO1 
P31749 
P31751 
Q9Y243 
P14672 
 
P62993 
P49840 
P49841 
P06213 
P35568 
Q9Y4H2 
P28482 
P27361 
P42336 
 
P42338 
 
O00329 
 
P27986 
O00459 
Q92569 
O15530 
Q07889 
Q07890 
P01112 
P01116 
P01111 
P10398 
P04049 
P15056 
Q02750 
P36507 
P42345 
Q92934 
Q12778 
RAC-alpha serine/threonine-protein kinase 
RAC-beta serine/threonine-protein kinase 
RAC-gamma serine/threonine-protein kinase 
Solute carrier family 2, facilitated glucose transporter 
member 4 
Growth factor receptor-bound protein 2 
Glycogen synthase kinase-3 alpha 
Glycogen synthase kinase-3 beta 
Insulin receptor 
Insulin receptor substrate 1 
Insulin receptor substrate 2 
Mitogen-activated protein kinase 1 
Mitogen-activated protein kinase 3 
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic 
subunit alpha isoform 
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic 
subunit beta isoform 
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic 
subunit delta isoform 
Phosphatidylinositol 3-kinase regulatory subunit alpha 
Phosphatidylinositol 3-kinase regulatory subunit beta 
Phosphatidylinositol 3-kinase regulatory subunit gamma 
3-phosphoinositide-dependent protein kinase 1 
Son of sevenless homolog 1 
Son of sevenless homolog 2 
GTPase HRas 
GTPase KRas 
GTPase NRas 
Serine/threonine-protein kinase A-Raf 
RAF proto-oncogene serine/threonine-protein kinase 
Serine/threonine-protein kinase B-raf 
Dual specificity mitogen-activated protein kinase kinase 1 
Dual specificity mitogen-activated protein kinase kinase 2 
Serine/threonine-protein kinase mTOR 
Bcl2-associated agonist of cell death 
Forkhead box protein O1 
 
 
 Posteriorly, the uniprot code for the Homo sapiens of each of the key proteins was retrieved 
(Table 1 and 2), in order to eliminate interactions described in other species, and were submitted 
into the IntAct Molecular Interaction Database. Different databases (IntAct, String and BioGRID) 
were tested and IntAct demonstrated to be more complete and reliable, as well as including only 
curated data. 
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 All data recovered from IntAct were imported to Cytoscape and the interaction networks 
were built for each protein.   
 In order to get the interactome for the AD pathway and the IS pathway, the interactomes 
of each protein from each pathway were merged and organized for better visualization. Also, the 
list of all protein interactions of each pathway were crossed so as to identify coincident proteins. 
These were marked in a different colour in the network.  
 Also a network for the synapse was built. All synaptic proteins were obtained by a Gene 
Ontology (GO_0045202) predefined list already assembled in the literature.  
 
3.3.  Neuronal cell models 
 
 The use of human in vitro neuronal cell models has been fundamental to understand the 
functioning of the nervous system. Cell models play an important role in reducing animal testing 
and provide a better understanding of human cells, because of the identical genome.  
 The culture of neuronal cells is hard to achieve, since mature neurons do not undergo 
significant cell division. For this purpose, it is necessary to use cell lines that are derived from 
neuronal tumours and have become immortalized. These cells are easier to grow and present small 
variability between cultures.  
 
3.3.1.  SH-SY5Y cell  line 
 SH-SY5Y (ATCC® CRL­2266™) cell line are a subclone of the neuroblastoma cell line SK-N-
SH. This cell line was generated from a bone marrow biopsy in 1970. It is composed of two types of 
cells: neuroblast-like and epithelial-like. The SH-SY5Y cell line can be differentiated into a neuronal 
mature human state through different mechanisms, depending on the neuron subtype required 
(adrenergic, cholinergic or dopaminergic). This cell line has been extensively used as a neuronal cell 
model due to the resemblance to primary neurons.  
 Both differentiated and non-differentiated SH-SY5Y cells are used in in-vitro experiments, 
depending on the target in study. Undifferentiated cells tend to grow in clusters and are 
morphologically neuroblast-like with non-polarized cell bodies. They also lack mature neuronal 
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markers. In contrast, differentiation into neuronal-like cells leads to different events, including the 
induction of neuron-specific enzymes, neurotransmitter and neurotransmitter receptors, 
formation and extension of neuritic processes, synaptophysin-positive functional synapses and 
increased electrical excitability of the plasma membrane. Thus for this reason we opted to 
differentiate the SH-SY5Y cell line and use it in subsequent experiments. 
 
 
3.2.2. SH-SY5Y cell culture 
3.2.2.1.  Growth and maintenance of SH-SY5Y cell line 
 
 The complete growth medium used to maintain this cell line is composed of a 1:1 mixture 
of Eagle’s Minimum Essential Medium (MEM) and F12 supplemented with 10% of heat-inactivated 
Fetal Bovine Serum (FBS), 2nM L-Glutamine, sodium bicarbonate, sodium pyruvate and 1% of 
antibiotic/antimycotic.  
 Prior to use, cells were cryopreserved in liquid nitrogen at -196ºC with a cell freezing 
medium composed by complete growth medium supplemented with 5% (v/v) dimethyl sulfoxide 
(DMSO).  
 To use, cells were quickly thawed to 37ºC, 1ml of cell media was added to the vial and 
centrifuged at 1000 rpm for 3 minutes to remove the DMSO. The pellet of cells was re-suspended 
in fresh complete growth medium and seeded in a 100mm culture plate.  
 Cell cultures were maintained in an incubator at 37ºC with 5% CO₂ and 95% humidity. Every 
three days, complete growth medium was replaced until cell splitting. To split the cells, all medium 
was aspirated and cells were washed with 2 ml of pre-warmed Phosphate Buffered Saline (PBS). 
Afterwards, the PBS was aspirated and 2ml of 0,05% of Trypsin-EDTA solution was added to re-
suspend adherent cells. After cell detachment, 6ml of fresh complete growth medium was added 
to inactivate the trypsin, followed by centrifugation at 1000 rpm for 3 minutes in a 15ml vial. Finally, 
the supernatant was carefully discarded, cells were re-suspended in fresh medium and plated at 
the desired cell density. 
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3.2.2.2. Differentiation of SH-SY5Y cell line 
 The differentiation of this cell line is mainly achieved by the addition of Retinoic Acid (RA) 
to the complete growth medium.  
 The literature offers many options for the differentiation of the SH-SY5Y cell line, a protocol 
optimization was necessary to test the optimal conditions. For this, the most important variables 
on the protocols was the percentage of fetal bovine serum (FBS) used and the time of exposure to 
the RA. Four hundred thousand cells were plated in each well of a 6-well plate (diameter 34.8 mm) 
and two concentrations of FBS (1% and 10%) were tested in combination with 10 µM of RA. Phase-
contrast photographs were taken at day 0, 3 and 5, and cell elongation and neurites outgrowth 
were assessed. 
 
 
3.2.2.3. Insulin treatment 
 Human insulin was obtained from Sigma-Aldrich (product code I3536) and reconstituted in 
PBS. To test the influence of insulin, cells were exposed to 0, 1, 10 and 100 nM of insulin in 
combination with serum free medium for 0, 10 and 60 minutes at 37ºC. 
 
 
3.3. Sample preparation and protein quantification 
 After treatments, cells were washed with ice-cold PBS and then collected using RIPA lysis 
buffer (Sigma, cat. #R0278) and a cocktail with protease and phosphatase inhibitor (cOmplete, 
EDTA-free, Roche, cat. #11873580001). Subsequently, lysates were sonicated during 10 seconds 
and stored at -20ºC. 
 Protein quantification was obtained using bicinchoninic acid (BCA) assay, using Pierce™ BCA 
Protein Assay kit (Thermo Fisher Scientific, cat. #23225). This assay relies on two different reactions. 
Initially, the ability of peptide bonds to reduce Cu²⁺ to Cu⁺. The amount of Cu²⁺ reduced is 
proportional to the amount of protein in the sample. This reaction is followed by the chelation of 
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molecules of BCA to one molecule of Cu⁺ forming a purple-coloured complex exhibiting a strong 
absorbance at 562 nm.  
 In order to determine the precise amount of protein in the sample, it is necessary to use a 
standard where the amount of protein is previously known as described in the table 3.  
 
Table 3- Standards used in BCA. Bovine Serum Albumin (BSA). 
Standard BSA (µL) Buffer (µL) Protein mass (µg) 
P0 - 25 0 
P1 1 24 2 
P2 2 23 4 
P3 5 20 10 
P4 10 15 20 
P5 20 5 40 
  
 For protein quantification, 5 μl of SH-SY5Y lysates were used. Standards and samples were 
incubated with 200 μl of working reagent previously prepared by adding 50 parts of reagent A and 
1 part of reagent B from the Pierce™ BCA Protein Assay kit. The plate was incubated for 30 minutes 
at 37ºC and the absorbance was immediately measured at 562nm using TECAN Infinite M200. 
 
 
3.4. Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) 
 
 SDS-PAGE is used to separate proteins from a mixture based on molecular weight. This 
technique relies on the capacity of proteins to migrate through gel pores under an electrical field. 
SDS needs to be used in this method to remove different protein charges and in order to charge 
negatively all proteins, enabling the sample to migrate from a negative to a positive pole. A reducing 
agent (β-mercaptoethanol) is also used in combination with SDS to dissociate proteins before 
loading the gel. This ensures that all disulphide bonds are cleaved, linearizing the proteins so that 
the tertiary and quaternary protein structures do not interfere with the migration in the gel.  
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 In this work, samples were subjected to 5-20% gradient SDS-PAGE in a Hoefer 
electrophoresis system. The gel is composed of 2 phases, the staking gel, where the samples are 
loaded, and the resolving gel, where the proteins are separated. The resolving gel has a linear 
progression in the concentration of acrylamide from top to bottom, in order to get a wider 
separation range.  
 Firstly, the resolving gel solution was prepared and carefully pipetted into the mounted 
electrophoresis equipment and distilled water added on top to reduce toxicity to the environment. 
The gel was left for 1h at room temperature in order to polymerize. Subsequently, the stacking gel 
solution was prepared, the water from the equipment was poured out and the solution loaded on 
top of the running gradient gel. A comb was inserted to mark the wells for the samples and the gel 
was left a further 1 hour to polymerize at room temperature.  
 In parallel, samples were prepared by adding to the protein sample solution, ¼ volume of 
4X loading buffer (LB) and boiled for 10 minutes. The samples and the molecular weight marker 
(Precision Plus ProteinTM Dual Color Standards, Bio Rad, cat. #1610374) were then carefully loaded 
into the wells and separated by electrophoresis at 90 mA of electric current for 3 to 4 hours. 
 
3.5. Western blot 
 
 Western blot or Immunoblot is a widely used technique for detection and analysis of 
proteins. This technique is used to detect specific proteins in complex samples like cell lysates or 
body fluids. Following the SDS-PAGE, the proteins are transferred to a solid membrane, in this case, 
a nitrocellulose membrane, by an electrophoretic field while the proteins positions remain 
unaltered. Once in the membrane, proteins are suitable for detection by protein staining or 
labelling by specific antibodies. The membranes can be stained with Ponceau S, to confirm protein 
transfer and assess equal gel loading. Before incubating with antibodies, the membranes need to 
be blocked with either non-fat milk or BSA, in order to block non-specific sites of the primary 
antibody. Membranes are then incubated with the specific primary antibody followed by the 
secondary antibody. After the binding, the antibodies can be detected by chemiluminescence and 
detected using appropriate equipment.  
 Transfer was confirmed by Ponceau staining. Ponceau S is a dye that binds to protein 
positive amino acids and to non-polar protein regions in a non-covalent form. For this purpose, the 
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membrane was hydrated with Tris-buffered saline solution (TBS) during 10 minutes under agitation, 
followed by the ponceau staining solution for 5 minutes. After the incubation, the solution was 
removed from the membrane using deionized H₂O to remove the excess.  
 After confirming the transfer and totally removing ponceau staining, membranes were 
blocked with 5% BSA in tris buffered saline tween (TBS-T) 1x for 4 hours. The membranes were 
subsequently washed in TBS-T 1x for 10 minutes and incubated with a specific primary antibody 
overnight. In the next morning, membranes were washed six times with TBS-T 1x for 10 minutes 
each and incubated with the appropriated secondary antibody for 2h. Following the incubation, the 
membranes were washed six times with TBS-T 1x for 10 minutes each and incubated with enhanced 
luminescence (ECL) detection kit for 5 minute, followed by visualization of the membrane using 
ChemiDoc Imaging System. 
  
 
3.6. Resazurin assay 
Resazurin is a cell permeable redox indicator that can be used to monitor cell viability. Resazurin 
is a blue dye that can be dissolved in physiological buffers or cell culture medium. Cells with active 
metabolism can reduce resazurin into resorufin, which is pink and fluorescent. The quantity of 
resorufin that is produced is proportional to the number of viable cells which can be quantified 
using a microplate equipped with fluorimeter with a 560 nm excitation and 590 nm emission filter 
set. 
For this assay, differentiated SH-SY5Y cells were pre-treated with different concentrations of 
insulin (0, 1, 10 and 100 nM) for 0, 10 and 60 minutes, followed by incubation with 10 µg/ml of 
resazurin for 4 hours.  
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4. Results and discussion 
 
 
4.1. Diabetes correlates with poor cognitive scores 
 The MMSE was applied to the pcb-Cohort and scored from 0-30. Cut-off was set at ≥7 years 
of literacy and MMSE cut-off at 27 66. Those equal to or below the cut-off are scored as having 
cognitive deficit, those above the cut-off as normal. Individuals were also analyzed with respect to 
comorbidities (Table 4). A positive correlation with neuropathological disorders was obtained for 
the three MMSE cut-off analyses (Table 4). In effect one can confirm that the diagnosis of 
neuropathological conditions was correct in this population. With respect to other comorbidities 
the strongest correlation was obtained with diabetes (DM) and MMSE 27 with a p-value of 0.072 
(Table 4). 
 
Table 4- Association of cognitive performance with comorbidities. Taken from:67 
 
 
 
 
 Additionally the correlation of diabetes with other factors was also evaluated. The CDR 
applied a 0 to 3 score 61, where 0=Normal, 0.5=suspect, questionable or very mild dementia, and 
CDR≥1(1, 2, 3)=mild, moderate or severe dementia. The reduced GDS was also applied, version 
GDS-15 62. Results were scored from 0-15, where 0-4 is normal and above 5 is consistent with 
depression. IADL was applied to evaluate eight daily functionalities 64. Results are shown in table 5. 
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Table 5- Association of diabetes with cognitive evaluation and ApoE genotyping 
 
 
 
 A strong correlation between poor cognitive performance and diabetes was again observed 
(table 5) with a p-value of 0.072 for MMSE27 and p-value of 0.078 for CDR and MMSE positive 
individuals. Additionally it is also clear that the ApoE-ɛ2 genotype (p-value of 0.057) is protective 
for diabetes, of note and as described in the introduction, it is also protective for AD. 
 The data here presented provides strong preliminary evidence linking poor cognitive scores 
to diabetes and validates the need to carry out further molecular and cell biology based studies. 
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4.2. Network analysis 
4.2.1. Key proteins interactomes 
 
 In order to understand the interrelationship of proteins we are increasingly resorting to 
mapping complex networks using a systems biology approach. Often the central point 
(protein/node) is a protein whose involvement has been well characterized for a given pathology; 
such as the APP in AD. Hence using the list of proteins in Table 1 and 2, see methods above, the 
interactome for each of the proteins involved in AD and IS was constructed. In essence a network 
was built for every key protein in both AD and IS pathway. An example is shown in Figure 5.  
 
 
 
Figure 5 - APP interactome, as example. 
 
To simplify the data output the number of interacting proteins with each of the search 
nodes/proteins is shown in Table 6 and 7. Of note, the IntAct database identifies the gene but given 
that we are discussing proteins the term protein will be used. 
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Table 6 - AD proteins and the number of interactors involved 
 Gene name Number of interactors 
AD APOE 
APP 
BACE1 
MAPT / TAU 
PSEN1 
PSEN2 
ADAM10 
ADAM17 
APH1A 
APH1B 
CAPN1 
CAPN2 
CASP3 
CASP7 
CDK5 
CDK5R1 
IDE 
LPL 
LRP1 
MME/NEP 
NCSTN 
PSENEN 
RTN3 
RTN4 
25 
84 
5 
28 
36 
21 
4 
8 
14 
1 
18 
11 
40 
12 
58 
7 
7 
14 
17 
81 
49 
7 
20 
38 
 
Table 7- IS proteins and the number of interactors involved 
 Gene name Number of interactors 
IS AKT1 
AKT2 
AKT3 
GLUT4/SLC2A4 
GRB2 
GSK3A 
GSK3B 
INSR 
IRS1 
IRS2 
MAPK1 
MAPK3 
PIK3CA 
PIK3CB 
PIK3CD 
144 
31 
7 
3 
760 
28 
199 
35 
23 
15 
87 
88 
38 
13 
9 
33 
 
PIK3R1 
PIK3R2 
PIK3R3 
PDPK1 
SOS1 
SOS2 
HRAS 
KRAS 
NRAS 
ARAF 
RAF1 
BRAF 
MAP2K1 
MAP2K2 
MTOR 
BAD 
FOXO1 
186 
50 
123 
49 
31 
15 
42 
56 
30 
80 
106 
39 
60 
17 
64 
34 
33 
 
 
 
Consequently all the interacting networks for AD were merged, the same was carried out 
for the IS. Highly complex networks were obtained. 
Obviously it is difficult to simultaneously address the functional significance of all the 
proteins/nodes present in the merged networks. Hence, a subsequent analysis was carried out to 
identify, which of the proteins present in the AD and IS pathways were also relevant to the synapse. 
 
 
4.2.2.       Synapse network correlation     
  
 A synapse proteome network including 6900 proteins was created (data not shown) to 
correlate the presence of AD proteins in the synapse. This is singularly important as in AD synapses 
are destroyed, causing loss of communication between neurons and leading, in a final stage, to 
neuronal death. For this purpose, the 511 proteins retrieved from the merged network of key AD 
proteins, were crossed with the 6900 synapse proteins found in the literature. It was possible to 
identify that AD and the synapse are related, as 88% of the retrieved AD pathway proteins can be 
found in the synapse proteome (Supplementary table 1). 
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  The same procedure was carried out for the IS pathway, in order to see the relevance of IS 
in the synapse. Although the number of IS proteins retrieved is much higher, 79% of these were 
present in the synapse which highlights the relevance of IS pathway to the synapse (Supplementary 
table 1). 
 If one considers the overlap between merged networks for the AD and IS pathways there 
are 156 shared nodes/proteins, these are discussed in more detail below, but of these 150 are also 
present in the synapse (Supplementary table 1). In other words 96% of AD and IS shared proteins 
can be found in the synapse, re-enforcing that the IS pathway in the synapse may be of critical 
importance to AD. 
 
Table 8- Number and percentage of proteins involved in each pathway and in the synapse. 
Pathway Number of proteins 
retrieved from the 
disease 
Number of proteins 
coincident with the 
synapse 
Percentage of 
coincident proteins 
with the synapse 
AD pathway 511 449 88% 
IS pathway 1728 1358 79% 
Coincident in 
AD and IS 
pathway 
 
156 
 
150 
 
96% 
 
  
 
 
4.2.3.  Alzheimer’s disease and insulin signaling pathway correlation 
  
 As mentioned above, 156 proteins/nodes were identified as coincident in AD and the IS 
pathways, but further analysis was required. The network of all AD retrieved proteins served as a 
template and all 156 proteins (Table 7) were marked to help visualize common proteins and their 
probable functions in AD (Figure 6 and 7). 
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Table 9- Proteins identified as coincident in AD and the IS pathway. 
Gene names Proteins full name 
A2M 
ABL1 
ACTB 
ACTN1 
AKT1 
AKT2 
AKT3 
ALAS1 
ANXA6 
APBB3 
APOA1 
APOB 
APP 
AR 
ARRB2 
ASCC2 
ATF2 
ATP5A1 
BCAR3 
BCL2L1 
BIN1 
CALR 
CASP3 
CAST 
CCNB1 
CCND1 
CCNI 
CCT3 
CCT7 
CCT8 
CDC37 
CDC42 
CDH1 
CDKN1A 
CDKN1B 
CEP126 
CFL1 
COPS6 
CREB3 
CRELD2 
CTNNB1 
CTSD 
CTTN 
DBN1 
DCTN1 
DIAPH1 
DLG1 
Alpha-2-macroglobulin 
Tyrosine-protein kinase ABL1 
Actin, cytoplasmic 1 
Alpha-actinin-1 
RAC-alpha serine/threonine-protein kinase 
RAC-beta serine/threonine-protein kinase 
RAC-gamma serine/threonine-protein kinase 
5-aminolevulinate synthase, nonspecific, mitochondrial 
Annexin A6 
Amyloid-beta A4 precursor protein-binding family B member 3 
Apolipoprotein A-I 
Apolipoprotein B-100 
Amyloid-beta A4 protein 
Androgen receptor 
Beta-arrestin-2 
Activating signal cointegrator 1 complex subunit 2 
Cyclic AMP-dependent transcription factor ATF-2 
ATP synthase subunit alpha, mitochondrial 
Breast cancer anti-estrogen resistance protein 3 
Bcl-2-like protein 1 
Myc box-dependent-interacting protein 1 
Calreticulin 
Caspase-3 
Calpastatin 
G2/mitotic-specific cyclin-B1 
G1/S-specific cyclin-D1 
Cyclin-I 
T-complex protein 1 subunit gamma 
T-complex protein 1 subunit eta 
T-complex protein 1 subunit theta 
Hsp90 co-chaperone Cdc37 
Cell division control protein 42 homolog 
Cadherin-1 
Cyclin-dependent kinase inhibitor 1 
Cyclin-dependent kinase inhibitor 1B 
Centrosomal protein of 126 kDa 
Cofilin-1 
COP9 signalosome complex subunit 6 
Cyclic AMP-responsive element-binding protein 3 
Cysteine-rich with EGF-like domain protein 2 
Catenin beta-1 
Cathepsin D 
Src substrate cortactin 
Drebrin 
Dynactin subunit 1 
Protein diaphanous homolog 1 
Disks large homolog 1 
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DLG4 
DNAJB1 
DNM1 
DYNC1H1 
EEF1A1 
EGFR 
EPB41L3 
EZR 
FHL2 
FIBP 
FLNA 
FLNB 
FTL 
FYN 
GAPDH 
GCDH 
GFAP 
GOLGA2 
GRB2 
GSK3A 
GSK3B 
HP 
HSCB 
HSP90AA1 
HSP90AB1 
HSPA1A 
HSPA8 
HSPB1 
IKBKE 
IMPDH2 
IRAK2 
JAK3 
JUN 
KSR1 
LAMTOR1 
LMNA 
LRRK2 
LUC7L2 
MAD2L1 
MAP3K5 
MAPT 
MDM2 
MED4 
MEOX2 
MET 
MLH1 
MPP1 
MYH9 
NIF3L1 
Disks large homolog 4 
DnaJ homolog subfamily B member 2 
Dynamin-1 
Cytoplasmic dynein 1 heavy chain 1 
Elongation factor 1-alpha 1 
Epidermal growth factor receptor 
Band 4.1-like protein 3 
Ezrin 
Four and a half LIM domains protein 2 
Acidic fibroblast growth factor intracellular-binding protein 
Filamin-A 
Filamin-B 
Ferritin light chain 
Tyrosine-protein kinase Fyn 
Glyceraldehyde-3-phosphate dehydrogenase 
Glutaryl-CoA dehydrogenase, mitochondrial 
Glial fibrillary acidic protein 
Golgin subfamily A member 2 
Growth factor receptor-bound protein 2 
Glycogen synthase kinase-3 alpha 
Glycogen synthase kinase-3 beta 
Heterochromatin protein 1 
Iron-sulfur cluster co-chaperone protein HscB, mitochondrial 
Heat shock protein HSP 90-alpha 
Heat shock protein HSP 90-beta 
Heat shock 70 kDa protein 1A 
Heat shock cognate 71 kDa protein 
Heat shock protein beta-1 
Inhibitor of nuclear factor kappa-B kinase subunit epsilon 
Inosine-5'-monophosphate dehydrogenase 2 
Interleukin-1 receptor-associated kinase-like 2 
Tyrosine-protein kinase JAK3 
Transcription factor AP-1 
Kinase suppressor of Ras 1 
Ragulator complex protein LAMTOR1 
Prelamin-A/C 
Leucine-rich repeat serine/threonine-protein kinase 2 
Putative RNA-binding protein Luc7-like 2 
Mitotic spindle assembly checkpoint protein MAD2A 
Mitogen-activated protein kinase kinase kinase 5 
Microtubule-associated protein tau 
E3 ubiquitin-protein ligase Mdm2 
Mediator of RNA polymerase II transcription subunit 4 
Homeobox protein MOX-2 
Hepatocyte growth factor receptor 
DNA mismatch repair protein Mlh1 
55 kDa erythrocyte membrane protein 
Myosin-9 
NIF3-like protein 1 
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NUMB 
PAK2 
PHB 
PIN1 
PLEKHF2 
PNKD 
PPIA 
PPP1CA 
PRKAB1 
PSEN1 
PTPN1 
PTPN3 
PTPN4 
PTPN5 
Q53FC7 
Q96BE0 
RCAN1 
RET 
RHEB 
RPL18A 
RPL30 
RPP38 
RPS23 
RUVBL1 
RUVBL2 
SCAND1 
SDF4 
SHC1 
SLC1A2 
SLC25A5 
SNCA 
SORT1 
SPG21 
SPICE1 
SPTAN1 
SRC 
SRI 
STAT3 
STIP1 
STK4 
STUB1 
TERF1 
TFAP2A 
TGOLN2 
TIRAP 
TLE1 
TMED2 
TNPO1 
TP53BP2 
Protein numb homolog 
Serine/threonine-protein kinase PAK 2 
Prohibitin 
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 
Pleckstrin homology domain-containing family F member 2 
Probable hydrolase PNKD 
Peptidyl-prolyl cis-trans isomerase A 
Serine/threonine-protein phosphatase PP1-alpha catalytic subunit 
5'-AMP-activated protein kinase subunit beta-1 
Presenilin-1 
Tyrosine-protein phosphatase non-receptor type 1 
Tyrosine-protein phosphatase non-receptor type 3 
Tyrosine-protein phosphatase non-receptor type 4 
Tyrosine-protein phosphatase non-receptor type 5 
Heat shock 70kDa protein 6 (HSP70B') variant 
Uncharacterized protein 
Calcipressin-1 
Proto-oncogene tyrosine-protein kinase receptor Ret 
GTP-binding protein Rheb 
60S ribosomal protein L18a 
60S ribosomal protein L30 
Ribonuclease P protein subunit p38 
40S ribosomal protein S23 
RuvB-like 1 
RuvB-like 2 
SCAN domain-containing protein 1 
45 kDa calcium-binding protein 
SHC-transforming protein 1 
Excitatory amino acid transporter 2 
ADP/ATP translocase 2 
Alpha-synuclein 
Sortilin 
Maspardin 
Spindle and centriole-associated protein 1 
Spectrin alpha chain, non-erythrocytic 1 
Proto-oncogene tyrosine-protein kinase Src 
Sorcin 
Signal transducer and activator of transcription 3 
Stress-induced-phosphoprotein 1 
Serine/threonine-protein kinase 4 
E3 ubiquitin-protein ligase CHIP 
Telomeric repeat-binding factor 1 
Transcription factor AP-2-alpha 
Trans-Golgi network integral membrane protein 2 
Toll/interleukin-1 receptor domain-containing adapter protein 
Transducin-like enhancer protein 1 
Transmembrane emp24 domain-containing protein 2 
Transportin-1 
Apoptosis-stimulating of p53 protein 2 
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TTI1 
TUBB 
UCHL1 
UMPS 
VCAM1 
XIAP 
YWHAE 
YWHAG 
YWHAQ 
YWHAZ 
ZDHHC17 
TELO2-interacting protein 1 homolog 
Tubulin beta chain 
Ubiquitin carboxyl-terminal hydrolase isozyme L1 
Uridine 5'-monophosphate synthase 
Vascular cell adhesion protein 1 
E3 ubiquitin-protein ligase XIAP 
14-3-3 protein epsilon 
14-3-3 protein gamma 
14-3-3 protein theta 
14-3-3 protein zeta/delta 
Palmitoyltransferase ZDHHC17 
 
  
A summary of AD and IS coincident proteins is shown in Figure 6. In Figure 7 are represented 
all AD proteins retrieved in grey and the coincident proteins also present in the IS pathway are 
shown in green. Also, the size of the nodes vary according to the amount of control that this node 
exerts over the interactions of other nodes in the network. In other words, the node will grow 
according to the number of interactions it performs between communities. This method of analysis 
allows one to identify proteins with higher impact in different protein pathways.  
 
Figure 6- Venn diagram of AD and IS proteins 
 
(511 proteins) 
(1728 proteins) 
(156 proteins) 
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Figure 7- All retrieved AD proteins. Grey nodes correspond to proteins only from AD while green nodes correspond to 
coincident proteins from AD and IS pathways. Bigger nodes correspond to proteins that are bridges between different 
communities, re-enforcing their importance by connecting diverse key proteins. 
 
 From the Figure 7, APP is clearly a central hub, and can be visualized as the protein 
with highest impact on AD. On a second plan, a few other proteins appear as central nodes, such 
as microtubule-associated protein tau (MAPT), presenilin-1 and 2 (PSEN1 and PSEN2), 
apolipoprotein E (ApoE), caspase-3 (CASP3), cyclin-dependent kinase 5 (CDK5) and Nicastrin 
(NCSTN).   
 Tau protein and ApoE also contribute to AD hallmarks, having great importance in the 
disease development as already discussed. PSEN-1, PSEN-2 and NCSTN are a part of the γ-secretase 
complex, responsible for APP cleavage. PSEN-1 and 2 mutations can cause autosomal dominant 
forms of early-onset AD68, meaning that although they are involved in both pathways of APP 
cleavage, they play a major role in Aβ formation. Also CASP3 appears prominently and in association 
with the IS pathway. This protein is involved in the start of the cascade of caspases responsible for 
execution of apoptosis, leading to neuronal death. Insulin is capable of reducing CASP3 activity in 
retinal neurons, preventing apoptosis69. Impaired insulin signalling may play a pivotal role in the 
activation of apoptosis cascade. Finally, CDK5 also appears highlighted. A protein from the class of 
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proline-directed serine/threonine-protein kinases, involved in many important cellular processes 
such as neuronal cell cycle arrest and differentiation, apoptosis, regulation by phosphorylating key 
proteins in neuronal survival, axonal and neurite growth, synaptic plasticity and neurotransmission 
and is also able to phosphorylate Tau70.  
 In order to analyse all proteins together, a gene ontology (GO) study was conducted on 
proteins coincident in the AD and IS pathways. Biological processes and molecular functions were 
assessed to understand the molecular mechanisms behind AD and also the mechanisms of common 
proteins between AD and IS pathways. The GO analysis was performed using PANTHER. The output 
provides the number of proteins involved in the process from the 156 protein input list; a p-value 
calculated by binomial statistic is also presented (Tables 12 and 13). This p-value represents the 
probability that the number of genes observed in the category occurred by chance, in comparison 
with a reference database list. A small p-value indicates that the observed number is significant and 
potentially interesting. 
 Regarding the 511 proteins in the AD interactome network from this study, and with 
respect to biological processes (Table 8), the response to stimulus appeared with the highest 
number of hits, indicating that many of the proteins are key signal transducers. However, by 
considering the p-value, other processes appear to be more significant. With the lowest p-value 
being obtained for cellular component organization, which in AD is completely deregulated. From 
this analysis, more than 50% of the AD set of proteins appears to be involved in this process. In this 
set, all microtubule and microtubule associated proteins appear, namely microtubule-associated 
protein tau, one of the major proteins involved in AD. Furthermore, many nodes also appear to be 
associated with cell communication and signalling, with almost 50% of our dataset of proteins 
present in these categories and with relatively low p-values. This is suggestive of a high impact that 
this disease can have in cell signalling.  
 In the molecular functions (Table 9), with 90% of representation and an absurdly low p-
value, we identified protein binding. Suggesting that this disease is not dependent on proteins alone 
but more protein complexes, which are more difficult to target than a single protein. It also 
reinforces that AD is a complex disease and many proteins can influence it. Of note, receptor 
binding was one of the top hits, with 20% of proteins from the set being able to bind to a receptor, 
probably leading to cascades of events. These cascades will lead to phosphorylation of other 
proteins, involving protein kinases and protein kinase binding, which was a molecular function 
associated with 14% of proteins (Table 9). This is a highly relevant molecular function, for instance 
playing an important role in tau hyperphosphorylation. 
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Table 10- Biological process analysis of interesting processes from AD proteins. 
Biological process Number of proteins % from total P value 
Response to stimulus 339/511 66% 6.03E-12 
Cellular component 
organization 
282/511 55% 3.59E-40 
Cell communication 244/511 48% 8.39E-21 
Signalling 238/511 47% 1.74E-19 
 
Table 11- Molecular function analysis of interesting functions from AD proteins. 
Molecular function Number of proteins % from total P value 
Protein binding 461/511 90% 1.36E-57 
Receptor binding 103/511 20% 9.34E-16 
Kinase binding 73/511 14% 1.38E-22 
 
 For only the coincident proteins, the same analyses with the same parameters were 
performed. Interestingly, all biological processes and molecular functions (Table 10 and 11) have 
an increase in the percentage of representation. All the identified processes have an important 
impact on AD and the fact that all increased can mean that insulin signalling probably plays a pivotal 
role in many key proteins associated with AD. 
 
Table 12- Biological process analysis of interesting processes from AD core proteins and only coincident proteins with IS 
pathway. 
Biological process Number of proteins % from total P value 
Response to stimulus 120/156 77% 1.51E-18 
Cellular component 
organization 
104/156 67% 3.79E-23 
Cell communication 90/156 58% 5.07E-13 
Signalling 88/156 56% 2.44E-12 
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Table 13- Molecular function analysis of interesting functions from AD core proteins and only coincident proteins with IS 
pathway. 
Molecular function Number of proteins % from total P value 
Protein binding 152/156 97% 5.26E-30 
Receptor binding 46/156 30% 1.46E-12 
Kinase binding 42/156 27% 1.71E-23 
 
 
 
4.3.  SH-SY5Y differentiation 
 
Having established a strong correlation at a systems biology level, namely a strong overlap 
in the AD and IS networks it was deemed relevant to pursue correlations using a neuronal cell 
model.  
The literature offers many methods to differentiate the SH-SY5Y cell line such as to achieve 
a neuronal like morphology. Upon consulting various protocols, the concentration of medium FBS 
and the exposure time of RA were the variants less defined. Thus, in this study, contrast-phase 
photographs were taken at day 0, day 3 and day 5 to visualize morphological differences in 
undifferentiated and differentiated cells in the presence of 1% and 10% FBS supplemented with 10 
µM of RA.  
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Figure 8- Differentiation of SH-SY5Y cell line at different time points. The control is undifferentiated cells with complete 
growth medium. Both 1% FBS and 10% FBS were supplemented with 10 µM of RA. 
 
 
 Day 0 was the day after the seeding and no treatment had yet been performed, so all cells 
looked the same. At day 3, one can already distinguish 1% FBS and 10% FBS from the 
undifferentiated control. A more elongated phenotype and more neurites can be visualized in the 
1% and 10% FBS concentrations, but no major differences between them. At day 5, the cells in 1% 
FBS appear to have formed much more neurites than the cells in 10% FBS or the control. The 5 day 
at 1% FBS protocol induced cells into a more mature neuron type and for this reason, this was the 
protocol used for the rest of the experiments. 
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4.4. Western blot analysis  
 Western blots were conducted using SH-SY5Y differentiated cells for 5 days with 10 µM of 
RA and 1% FBS medium and treated with 0, 1, 10 and 100 nM of human insulin for 0, 10 and 60 
minutes to assess the effect of insulin in AD related proteins. For this purpose, the levels of total 
tau, tau phosphorylated at serine 396, total APP and APP phosphorylated at threonine 668 were 
assessed.  
 
 
 
 
 Figure 9- Total Tau expression in SH-SY5Y differentiated cells treated with insulin. A- Western blot analysis of SH-SY5Y 
lysates treated with different concentrations and exposure times of insulin. B- Ponceau staining as loading control. C-
Comparison of total Tau expression levels in different concentration and exposure times of insulin. 
 
 
 Regarding the levels of total Tau protein, a very small increase can be detected in the 10 
minutes exposure to insulin, mainly in the 100nM (higher concentration), followed by a decrease 
after 60 minutes exposure. This decrease may be explained by cellular death due to toxic 
concentrations of insulin. It is possible to deduce that insulin does not appear to influence the 
expression of total Tau protein, at least during small exposure periods, as tested here.  
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 For the phosphorylation of protein Tau, many residues appear phosphorylated in AD. The 
choice to study the serine 396 come from previous work from our laboratory pointing to a 
significant increase of phosphorylation at this residue in SH-SY5Y cells exposed to the Aβ peptide23 
and its importance in the formation of paired helical Tau filaments (PHF).  
 
 
 
 
 
 
 
Figure 10- Tau phosphorylation at serine 396 in SH-SY5Y differentiated cells treated with insulin. A- Western blot analysis 
of SH-SY5Y lysates treated with different concentrations and exposure times of insulin. B- Ponceau straining as loading 
control. C- Comparison of Tau phosphorylation at serine 396. 
 
 In relation to the phosphorylation of protein Tau at the serine 396, an increase can be 
detected independent of the concentrations of insulin and more dependent on the exposure time.  
 In order to better visualize the data referent to total Tau and Tau phosphorylated at serine 
396, a ratio was performed (Figure 11).  
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Figure 11- Ratio between Tau phosphorylated at the serine 396 and total Tau. 
 
From the ratio, it is possible to see that higher exposure times and higher concentrations 
of insulin can lead to an effect on Tau protein, but further studies are necessary to enable any 
conclusion. 
 
 
 
 
 
 Figure 12- Total APP expression in SH-SY5Y differentiated cells treated with insulin. A- Western blot analysis of SH-SY5Y 
lysates treated with different concentrations and exposure times of insulin. B- Ponceau straining as loading control. C- 
Comparison of total APP expression levels in different concentrations and exposure times of insulin. 
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 Regarding APP, in the 10 minutes of exposure to insulin, an increase in the expression can 
be observed. However, while the SH-SY5Y cells were exposed to insulin for 60 minutes, a drastic 
decreased of total levels of APP in the higher concentrations can be noticed. A study performed in 
mice showed that the brain insulin receptor signalling mediated APP processing71, that is concurrent 
with the 60 minutes results reported. From the data here presented it seems reasonable to deduce 
that even short exposures to insulin appear to increase APP expression and possible APP processing. 
However to proof this further experimentation is necessary. 
 APP processing is intrinsically associated with its phosphorylation state. This applies to its 
intracellular trafficking as well as cleavage via different pathways and even Aβ production72,73. Thus 
the phosphorylation at threonine 668 of APP was assessed. The phosphorylation of this specific 
residue was previously shown to be involved APP cleavage, promoting the amyloidogenic 
pathway10. 
 
 
 
 
Figure 13- APP phosphorylation at threonine 668 in SH-SY5Y differentiated cells treated with insulin. A- Western blot 
analysis of SH-SY5Y lysates treated with different concentrations and exposure times of insulin. B- Ponceau straining as 
loading control. C- Comparison of APP phosphorylation at threonine 668 in different concentrations and exposure times 
of insulin. 
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 It is possible to visualize a high increase in the phosphorylation of APP thr668 when exposed 
for 10 minutes to different concentration of insulin, followed by a decrease at 60 minutes of 
exposure. From these results it is possible to conclude that the insulin signalling may actually play 
a role in determining APP phosphorylation and be putatively involved in Aβ production. The 
decrease in the phosphorylation of this residue at 60 minutes of insulin exposure may be related to 
a decrease in total APP. This question deserves to be further investigated. 
 Regarding the literature, almost all research conducted in insulin and AD report an anti-
amyloidogenic effect of insulin, due to a decrease in phosphorylation of APP at threonine 668, 
inactivation of GSK3β and decrease of β-secretase activity74. A study conducted in SH-SY5Y cells 
relate the decreasing phosphorylation of APP thr668 with the same concentrations of insulin used 
in this study, but for a higher exposure time (24h)74 and this appeared to be beneficial to AD. 
Another study made the same assumptions based in reduced APP Thr668 phosphorylation in long 
term administration in young adult mice with AD phenotype with intranasal administration of 
insulin75. While the data here presented also reveals a decreased phosphorylation at 60 minutes 
the shorter exposure period is contradictory. Namely shorter exposure periods appear to result in 
increased phosphorylation of APP-Thr668.   
 Insulin may actually play an important role as an anti-amyloidogenic but the results 
obtained in this study show that it may not be as linear as initially thought. The level of APP 
phosphorylation on Thr668 appears to be concentration and time of exposure dependent. Clearly 
the issue has to be further investigated. 
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4.5. Resazurin assay analysis 
 
A resazurin assay was performed to assess cell viability to confirm that the obtained results 
were real and not due to insulin toxicity and cellular death.  
 
Figure 14 -Resazurin assay. Viability of SH-SY5Y differentiated cells pre-treated with 0, 1, 10 and 100 nM of insulin for 0, 
10 and 60 minutes.  
 
As it can be seen in the Figure 13, no differences can be observed from cell viability, 
discarding the hypothesis that insulin could toxically interfere with the results. On the other hand, 
insulin can still be toxic at higher exposure times, as it can lead to Aβ production. This however, was 
not tested. 
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5. Conclusion 
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5. Conclusion 
 
 Growing evidence links impaired brain insulin signalling and insulin resistance to the 
development of AD. A correlation between diabetes and poor cognitive scores in MMSE tests were 
observed, linking diabetes to a deteriorating cognition. Additionally, carriers of the allele ApoE-ɛ2 
showed to be protected against diabetes, as seen for AD.  
 Nonetheless, the majority of proteins in AD and in IS pathways, were shown to be present 
in the synapse, re-enforcing their roles in synaptic signalling and plasticity. Coincident proteins on 
AD and IS pathways had 96% of representation in the synapse proteome, strengthening their role 
in the synapse as well as the relevance of IS to AD. 
 A gene ontology study was also conducted, in order to assess the most important biological 
processes and molecular function of the proteins involved. As for AD, response to stimulus, cellular 
component organization, cell communication, signalling, protein binding, receptor binding and 
kinase binding were categories with elevated representation. Regarding coincident proteins 
between AD and IS pathways, an increase in all categories was observed, suggesting that insulin 
plays a pivotal role in many AD related events.   
 Finally, the analysis of western blots performed in differentiated SH-SY5Y cells treated with 
different concentrations and exposure times of insulin displayed interesting preliminary results. For 
Tau protein, a decrease in the intracellular levels of total Tau and an increase in the phosphorylation 
of serine 396 was observed, with clear evidence when a ration between Tau phosphorylated and 
total Tau is performed. On the other hand, regarding APP, an increase in the expression at 10 
minutes of exposure followed by a decrease at 60 minutes of insulin exposure was observed. This 
can mean that insulin plays a role in the expression/processing of APP. As for the phosphorylation 
of threonine 668 of APP, which, in the literature, has been shown to favour Aβ production by 
promoting the cleavage by amyloidogenic pathway, was increased in the cells treated with insulin 
at 10 minutes, leading one to propose that short exposure to insulin may actually promote Aβ 
production.  
 Insulin signalling plays an unquestionable role in memory and cognition, and consequently 
in AD, but further work is necessary to understand all the mechanisms behind these cascades of 
events.   
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7. Appendix 
Cell Culture Solutions 
 PBS (1x) 
For a final volume of 500 mL, dissolve one pack of BupH Modified Dulbecco’s Phosphate Buffered 
Saline Pack (Pierce) in deionized H2O. Final composition: 
 8 mM Sodium Phosphate 
 2 mM Potassium Phosphate 
 140 mM Sodium Chloride 
 10 mM Potassium Chloride 
Sterilize by filtering through a 0.2 μm filter and store at 4°C. 
 
 10% FBS MEM:F12 (1:1) 
 4.805 g MEM 
 5.315 g F12 
 1.5 g NaHCO3 
 0.055 g Sodium Pyruvate 
 10 mL Streptomycin/Penicillin/Amphotericin solution 
 100 mL 10% FBS 
 2.5 mL L-glutamine (200 mM stock solution) 
Dissolve in deionized H2O. Adjust the pH to 7.2-7.3. Adjust the volume to 1000 mL with deionized 
H2O. 
For other combinations of FBS, replace 100 mL FBS with 30 mL (3% FBS MEM:F12), 10 mL (1% FBS 
MEM:F12) or remove FBS (serum-free MEM:F12). 
 
 
Western Blot Solutions 
 LGB (lower gel buffer) (4x) 
To 900 mL of deionized H2O add: 
 181.65 g of Tris 
 4 g of SDS 
Mix until the solutes have dissolved. Adjust pH to 8.9 and adjust the volume to 1 L with deionized 
H2O. 
 
 UGB (Upper gel buffer) (4x) 
To 900 mL of deionized H2O add: 
 75.69 g of Tris 
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Mix until the solute has dissolved. Adjust the pH to 6.8 and adjust the volume to 1 L with 
deionized H2O. 
 
 10% APS (ammonium persulfate) 
In 10 mL of deionized H2O dissolve 1 g of APS. Note: prepare fresh before use. 
 
 10% SDS (sodium dodecilsulfate) 
In 10 mL of deionized H2O dissolve 1 g of SDS. 
 
 Loading Gel Buffer (4x) 
 2.5 mL 1M Tris solution (pH 6.8) 2.5 mL (250 mM) 
 0.8 g SDS (8%) 
 4 mL Glicerol (40%) 
 2 mL β-mercaptoethanol (2%) 
 1 mg Bromofenol blue (0.01%) 
Adjust the volume to 10 mL with deionized H2O. Store in darkness at room temperature. 
 
 1 M Tris (pH 6.8) solution 
To 150 mL of deionized H2O add: 
 30.3 g Tris base 
Adjust the pH to 6.8 and adjust the final volume to 250 mL with deionized H2O. 
 
 10x Running Buffer 
 30.3 g Tris (250 mM) 
 144.2 g Glycine (2.5 M) 
 10 g SDS (1%) 
Dissolve in deionized H2O, adjust the pH to 8.3 and adjust the volume to 1 L. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
67 
 
Supplementary table 1- All synapse proteins
 
A0A024R
5S0 
A0A1B0G
TW0 
A1BG 
A1DRY3 
A2M 
A4GALT 
A6NNT2 
A8K1F4 
A8KAD6 
AAK1 
AAMDC 
AARD 
AARSD1 
AASS 
AATK 
ABCA1 
ABCA2 
ABCA3 
ABCB7 
ABCC1 
ABCC2 
ABCC4 
ABCD1 
ABCD3 
ABCE1 
ABCF2 
ABCF3 
ABCG2 
ABCG4 
ABCG5 
ABHD11 
ABHD15 
ABHD5 
ABI1 
ABI2 
ABI3 
ABI3BP 
ABL1 
ABL2 
ABLIM1 
ABLIM3 
ABR 
ABT1 
ACACA 
ACAD8 
ACAD9 
ACADVL 
ACAP1 
ACAT2 
ACBD5 
ACD 
ACE2 
 
ACHE 
ACIN1 
ACLY 
ACOT7 
ACP1 
ACP6 
ACSBG1 
ACSL3 
ACSL4 
ACSL5 
ACTA1 
ACTA2 
ACTB 
ACTBL2 
ACTC1 
ACTG1 
ACTG2 
ACTL6B 
ACTL7A 
ACTN1 
ACTN2 
ACTN3 
ACTN4 
ACTR1B 
ACTR2 
ACTR3 
ACTR3B 
ACTR6 
ACTRT1 
ACVR1 
ACVR2A 
ACVRL1 
ADAM10 
ADAM15 
ADAM17 
ADAM20 
ADAM22 
ADAM9 
ADAMTS
12 
ADAMTSL
4 
ADAP1 
ADAP2 
ADAR 
ADARB2 
ADCK5 
ADCY3 
ADCYAP1 
ADCYAP1
R1 
ADD1 
ADD3 
ADGRA1 
 
ADGRA2 
ADGRA3 
ADGRB2 
ADGRB3 
ADGRL1 
ADGRL2 
ADH6 
ADIRF 
ADNP 
ADO 
ADORA1 
ADORA2
A 
ADRA1B 
ADRA1D 
ADRA2B 
ADRA2C 
ADRB1 
ADRB2 
ADRB3 
ADRM1 
AEBP2 
AEN 
AES 
AFAP1 
AFARP1 
AFDN 
AFG3L2 
AGAP1 
AGBL5 
AGER 
AGFG1 
AGGF1 
AGO1 
AGO2 
AGO3 
AGO4 
AGPS 
AGR3 
AGRN 
AGTPBP1 
AGTR1 
AGTRAP 
AGXT 
AHCTF1 
AHDC1 
AHI1 
AHNAK 
AHNAK2 
AHSA1 
AHSG 
AICDA 
AIDA 
AIFM1 
 
AIFM3 
AIG1 
AIM1 
AIM2 
AIMP2 
AIP 
AIPL1 
AIRE 
AJAP1 
AK2 
AK3 
AK5 
AK8 
AKAP1 
AKAP10 
AKAP11 
AKAP12 
AKAP14 
AKAP17A 
AKAP2 
AKAP5 
AKAP6 
AKAP7 
AKAP8 
AKAP8L 
AKAP9 
AKIRIN1 
AKT1 
AKT2 
AKTIP 
ALAS1 
ALB 
ALCAM 
ALDH18A
1 
ALDH3A2 
ALDH6A1 
ALDH7A1 
ALDH8A1 
ALDOA 
ALDOB 
ALG8 
ALKBH3 
ALKBH8 
ALOX5 
ALPP 
ALS2 
ALS2CR1
1 
ALS2CR1
2 
ALYREF 
AMBRA1 
AMER1 
 
AMFR 
AMIGO2 
AMMECR
1 
AMOT 
AMOTL1 
AMOTL2 
AMPD3 
AMPH 
AMZ2 
ANAPC10 
ANAPC15 
ANAPC4 
ANAPC5 
ANAPC7 
ANG 
ANGEL2 
ANGPT1 
ANGPTL4 
ANGPTL7 
ANK1 
ANK2 
ANK3 
ANKFY1 
ANKHD1 
ANKRA2 
ANKRD11 
ANKRD17 
ANKRD24 
ANKRD27 
ANKRD28 
ANKRD34
A 
ANKRD36
BP1 
ANKRD46 
ANKRD50 
ANKRD55 
ANKS1A 
ANKS1B 
ANKS4B 
ANKS6 
ANLN 
ANO3 
ANO5 
ANO9 
ANOS1 
ANP32A 
ANP32B 
ANTXR1 
ANTXR2 
ANXA1 
ANXA10 
ANXA11 
 
ANXA2 
ANXA6 
ANXA7 
AOAH 
AOC3 
AOPEP 
AP1B1 
AP1G1 
AP1G2 
AP1M1 
AP1M2 
AP1S1 
AP1S2 
AP1S3 
AP2A1 
AP2A2 
AP2B1 
AP2M1 
AP2S1 
AP3B1 
AP3B2 
AP3D1 
AP3M1 
AP3S1 
APAF1 
APBA1 
APBA2 
APBA3 
APBB1 
APBB1IP 
APBB2 
APBB3 
APC 
APCS 
APEX1 
APH1A 
APIP 
APLP1 
APLP2 
APOA1 
APOA4 
APOB 
APOBEC3
B 
APOBEC3
G 
APOC3 
APOE 
APOH 
APOL2 
APOL3 
APOL5 
APP 
APPBP2 
 
APPL1 
APTX 
AQP1 
AQP3 
AR 
ARAP2 
ARAP3 
ARC 
ARF1 
ARF4 
ARF5 
ARF6 
ARFGAP1 
ARFGAP3 
ARFGEF1 
ARFGEF2 
ARFGEF3 
ARFIP1 
ARFIP2 
ARHGAP1 
ARHGAP1
0 
ARHGAP1
1A 
ARHGAP1
5 
ARHGAP1
7 
ARHGAP2
1 
ARHGAP2
2 
ARHGAP2
4 
ARHGAP2
6 
ARHGAP3
1 
ARHGAP3
2 
ARHGAP3
3 
ARHGAP3
9 
ARHGAP4
4 
ARHGDIA 
ARHGDIB 
ARHGEF1
1 
ARHGEF1
2 
ARHGEF1
7 
 
ARHGEF1
9 
ARHGEF2 
ARHGEF3 
ARHGEF4 
ARHGEF5 
ARHGEF6 
ARHGEF7 
ARID3A 
ARID4B 
ARID5A 
ARID5B 
ARIH2 
ARKL1 
ARL1 
ARL15 
ARL16 
ARL2BP 
ARL3 
ARL4D 
ARL6IP1 
ARL8B 
ARMC1 
ARMC10 
ARMC6 
ARMC8 
ARMCX1 
ARMCX3 
ARNT2 
ARNTL 
ARNTL2 
ARPC1A 
ARPC1B 
ARPC2 
ARPC3 
ARPC4 
ARPC5 
ARPC5L 
ARR3 
ARRB1 
ARRB2 
ARRDC3 
ARVCF 
ARX 
ASAP1 
ASAP2 
ASB10 
ASB13 
ASB16 
ASCC1 
ASCC2 
ASF1A 
ASGR2 
ASH2L 
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ASIC1 
ASIC2 
ASIC4 
ASNA1 
ASNS 
ASPH 
ASRGL1 
ASTE1 
ASXL1 
ATAD1 
ATAD2B 
ATAD3A 
ATCAY 
ATF2 
ATF4 
ATF5 
ATF6 
ATF7 
ATF7IP 
ATG10 
ATG12 
ATG3 
ATG4A 
ATG4C 
ATG5 
ATG7 
ATG9A 
ATIC 
ATL2 
ATL3 
ATM 
ATN1 
ATP12A 
ATP13A2 
ATP1A1 
ATP1A2 
ATP1A3 
ATP1B1 
ATP2A2 
ATP2B1 
ATP2B2 
ATP2B4 
ATP4B 
ATP5A1 
ATP5B 
ATP5C1 
ATP5D 
ATP5F1 
ATP5G1 
ATP5H 
ATP5I 
ATP5J2 
ATP5L 
ATP5O 
ATP6AP1 
ATP6AP2 
ATP6V0A
1 
ATP6V0C 
ATP6V0D
1 
ATP6V1A 
ATP6V1B
1 
ATP6V1B
2 
ATP6V1E
1 
ATP6V1G
1 
ATP6V1H 
ATP7A 
ATPAF2 
ATPIF1 
ATR 
ATRN 
ATRX 
ATXN1 
ATXN10 
ATXN2 
ATXN3 
ATXN7 
ATXN7L3 
AUP1 
AURKA 
AURKB 
AURKC 
AVPI1 
AXIN1 
AXIN2 
AXL 
B2M 
B2R4U6 
B2R550 
B3GAT1 
B4DMS2 
B4DN30 
B4DRL9 
B4DYC6 
B4E2V5 
B4GALT1 
B7Z2Y1 
B9D1 
B9D2 
BAAT 
BABAM1 
BACE1 
BACH2 
BAD 
BAG1 
BAG2 
BAG3 
BAG4 
BAG5 
BAG6 
BAHCC1 
BAHD1 
BAI1 
BAIAP2 
BAIAP2L1 
BAIAP3 
BAK1 
BAMBI 
BANP 
BAP1 
BARD1 
BASP1 
BATF 
BATF3 
BAX 
BAZ1A 
BAZ2A 
BAZ2B 
BBC3 
BBS1 
BBS10 
BBS2 
BBS4 
BBS5 
BBX 
BCAP31 
BCAR1 
BCAR3 
BCAS3 
BCCIP 
BCKDHA 
BCKDK 
BCL10 
BCL11A 
BCL2 
BCL2L1 
BCL2L11 
BCL2L13 
BCL2L14 
BCL3 
BCL6 
BCL7B 
BCL9 
BCL9L 
BCLAF1 
BCOR 
BCR 
BCR/ABL 
fusion 
BDP1 
BECN1 
BEGAIN 
BEND3 
BEST4 
BET1 
BEX1 
BEX2 
BFSP2 
BHLHB9 
BHLHE40 
BICD1 
BID 
BIK 
BIN1 
BIN3 
BIRC2 
BIRC3 
BIRC6 
BLK 
BLMH 
BLNK 
BLOC1S1 
BLOC1S2 
BLOC1S3 
BLOC1S4 
BLOC1S5 
BLOC1S6 
BLVRB 
BLZF1 
BMF 
BMI1 
BMP2K 
BMP8A 
BMP8B 
BMPR1B 
BMPR2 
BMX 
BNIP1 
BNIP2 
BNIP3 
BNIP3L 
BNIPL 
BOLA2 
BOLA3 
BOP 
BOP1 
BORCS6 
BORCS8 
BPGAP1 
BPGM 
BPIFA1 
BPY2C 
BRAF 
BRAP 
BRCA1 
BRCA2 
BRD1 
BRD2 
BRD4 
BRD7 
BRE 
BRF1 
BRINP1 
BRIX1 
BRK1 
BRMS1 
BRMS1L 
BRPF3 
BRSK1 
BSCL2 
BSG 
BSN 
BTBD10 
BTBD2 
BTBD3 
BTF3 
BTG3 
BTK 
BTN2A2 
BTN2A3P 
BTRC 
BUB1 
BUB1B 
BUD31 
BYSL 
BZW2 
C10orf35 
C11orf57 
C11orf65 
C11orf84 
C12orf10 
C14orf1 
C14orf15
9 
C14orf16
6 
C15orf39 
C15orf57 
C15orf59 
C16orf74 
C17orf50 
C17orf53 
C17orf62 
C17orf67 
C17orf82 
C19orf25 
C19orf47 
C19orf57 
C19orf60 
C1QA 
C1QBP 
C1QL1 
C1QTNF1 
C1QTNF2 
C1QTNF3 
C1QTNF6 
C1QTNF8 
C1QTNF9 
C1QTNF9
B-AS1 
C1S 
C1orf105 
C1orf109 
C1orf116 
C1orf216 
C1orf52 
C1orf94 
C20orf14
1 
C20orf27 
C22orf39 
C2CD5 
C2orf73 
C2orf82 
C2orf88 
C3orf67 
C4A 
C4B 
C4BPA 
C4orf17 
C4orf3 
C4orf42 
C4orf46 
C6 
C6orf120 
C6orf141 
C6orf203 
C6orf222 
C7orf25 
C7orf43 
C7orf50 
C8orf30A 
C8orf33 
C8orf59 
C9JAW5 
C9orf106 
C9orf163 
C9orf72 
C9orf75 
C9orf78 
CAAP1 
CABLES1 
CABLES2 
CABP1 
CABP5 
CABYR 
CACHD1 
CACNA1A 
CACNA1B 
CACNA1C 
CACNA1F 
CACNA2D
1 
CACNB3 
CACNB4 
CACNG2 
CACYBP 
CAD 
CADM1 
CADPS 
CADPS2 
CALB1 
CALCA 
CALCOCO
1 
CALCOCO
2 
CALCR 
CALD1 
CALM1 
CALML3 
CALML5 
CALR 
CALU 
CALY 
CAMK1D 
CAMK2A 
CAMK2B 
CAMK2D 
CAMK2G 
CAMKK2 
CAMLG 
CAMSAP
2 
CAMSAP
3 
CAMTA2 
CANX 
CAP2 
CAPN1 
CAPN10 
CAPN11 
CAPN2 
CAPN3 
CAPN7 
CAPNS1 
CAPRIN1 
CAPRIN2 
CAPZA1 
CAPZA2 
CAPZB 
CARD10 
CARD11 
CARD9 
CARHSP1 
CARM1 
CASC1 
CASC3 
CASK 
CASKIN1 
CASP1 
CASP10 
CASP2 
CASP3 
CASP4 
CASP6 
CASP8 
CASP8AP
2 
CASP9 
CAST 
CAT 
CATSPER
1 
CAV1 
CAV2 
CAV3 
CBARP 
CBFA2T3 
CBFB 
CBL 
CBLB 
CBLC 
CBLL1 
CBLN4 
CBR1 
CBS 
CBWD1 
CBWD3 
CBWD5 
CBX1 
CBX3 
CBX4 
CBX6 
CBX8 
CBY1 
CC2D1A 
CC2D2A 
CCAR2 
CCBE1 
CCDC102
A 
CCDC102
B 
CCDC103 
CCDC113 
CCDC115 
CCDC120 
CCDC125 
CCDC13 
CCDC136 
CCDC14 
CCDC141 
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CCDC146 
CCDC149 
CCDC153 
CCDC155 
CCDC158 
CCDC18 
CCDC180 
CCDC181 
CCDC184 
CCDC185 
CCDC186 
CCDC187 
CCDC22 
CCDC24 
CCDC28A 
CCDC36 
CCDC43 
CCDC47 
CCDC50 
CCDC57 
CCDC59 
CCDC61 
CCDC7 
CCDC77 
CCDC8 
CCDC82 
CCDC85B 
CCDC85C 
CCDC88A 
CCDC88B 
CCDC90B 
CCDC93 
CCDC94 
CCHCR1 
CCK 
CCKAR 
CCKBR 
CCL14 
CCL21 
CCL22 
CCL28 
CCM2L 
CCNA2 
CCNB1 
CCNB1IP
1 
CCNC 
CCND1 
CCND2 
CCND3 
CCNDBP1 
CCNE1 
CCNE2 
CCNH 
CCNI 
CCNK 
CCNO 
CCNY 
CCNYL1 
CCP110 
CCR10 
CCR5 
CCSER1 
CCSER2 
CCT2 
CCT3 
CCT4 
CCT5 
CCT6A 
CCT6B 
CCT7 
CCT8 
CD109 
CD177 
CD2 
CD22 
CD24 
CD247 
CD27 
CD2AP 
CD2BP2 
CD300C 
CD36 
CD37 
CD3D 
CD3E 
CD3EAP 
CD44 
CD59 
CD63 
CD81 
CD9 
CD93 
CD97 
CDAN1 
CDC23 
CDC25A 
CDC25B 
CDC25C 
CDC27 
CDC34 
CDC37 
CDC42 
CDC42BP
A 
CDC42BP
B 
CDC42BP
G 
CDC42EP
1 
CDC42EP
2 
CDC42EP
3 
CDC42EP
4 
CDC42SE
1 
CDC42SE
2 
CDC5L 
CDC7 
CDC73 
CDCA2 
CDCA3 
CDCA5 
CDCA7L 
CDCA8 
CDCP1 
CDH1 
CDH10 
CDH15 
CDH2 
CDH23 
CDH3 
CDH4 
CDH5 
CDIPT 
CDK1 
CDK11A 
CDK11B 
CDK13 
CDK15 
CDK16 
CDK17 
CDK18 
CDK19 
CDK2 
CDK20 
CDK2AP1 
CDK3 
CDK4 
CDK5 
CDK5R1 
CDK5RAP
2 
CDK5RAP
3 
CDK6 
CDK7 
CDK9 
CDKL3 
CDKL5 
CDKN1A 
CDKN1B 
CDKN2A 
CDKN2B 
CDKN2C 
CDKN2D 
CDR2 
CDR2L 
CDRT15 
CDSN 
CDT1 
CEACAM
3 
CEBPD 
CEBPZ 
CELSR1 
CELSR2 
CELSR3 
CEMP1 
CEND1 
CENPA 
CENPB 
CENPE 
CENPF 
CENPJ 
CENPO 
CENPP 
CENPT 
CENPU 
CENPV 
CEP104 
CEP112 
CEP120 
CEP126 
CEP128 
CEP131 
CEP135 
CEP152 
CEP162 
CEP170 
CEP170P
1 
CEP19 
CEP192 
CEP250 
CEP290 
CEP295 
CEP350 
CEP44 
CEP55 
CEP57L1 
CEP63 
CEP68 
CEP70 
CEP72 
CEP76 
CEP83 
CEP89 
CEP95 
CEP97 
CEPT1 
CERS2 
CETN1 
CETN2 
CETP 
CFAP20 
CFAP206 
CFAP36 
CFAP53 
CFAP61 
CFHR4 
CFL1 
CFL2 
CFTR 
CGA 
CGGBP1 
CGN 
CGRRF1 
CHAF1A 
CHCHD2 
CHCHD3 
CHCHD6 
CHD1L 
CHD2 
CHD3 
CHD4 
CHD5 
CHD8 
CHDH 
CHEK1 
CHEK2 
CHERP 
CHFR 
CHGB 
CHKA 
CHM 
CHML 
CHMP1A 
CHMP1B 
CHMP2A 
CHMP2B 
CHMP3 
CHMP4A 
CHMP4B 
CHMP4C 
CHMP5 
CHMP6 
CHN1 
CHN2 
CHORDC
1 
CHPF 
CHPT1 
CHRD 
CHRM1 
CHRM2 
CHRM3 
CHRM4 
CHRM5 
CHRNA1 
CHRNA3 
CHRNA4 
CHRNA5 
CHRNA6 
CHRNA7 
CHRNB1 
CHRNB2 
CHRNB4 
CHRND 
CHRNG 
CHST15 
CHUK 
CHURC1 
CIAO1 
CIART 
CIB1 
CIB3 
CIC 
CIDEA 
CIRBP 
CISH 
CIT 
CKAP4 
CKAP5 
CKB 
CKS1B 
CLASP2 
CLCN2 
CLCN3 
CLCN7 
CLCNKB 
CLDN12 
CLEC17A 
CLEC1A 
CLEC3B 
CLEC4D 
CLEC4G 
CLEC4M 
CLEC7A 
CLGN 
CLIC1 
CLIC5 
CLINT1 
CLIP4 
CLK2 
CLK3 
CLN3 
CLN5 
CLN6 
CLNK 
CLNS1A 
CLOCK 
CLPP 
CLPTM1L 
CLRN3 
CLSTN1 
CLSTN3 
CLTA 
CLTB 
CLTC 
CLTCL1 
CLU 
CLUH 
CMAS 
CMBL 
CMIP 
CMSS1 
CMTM3 
CMTM5 
CMTM7 
CMTM8 
CMTR1 
CMYA5 
CNBP 
CNDP2 
CNGA3 
CNGB1 
CNIH2 
CNIH3 
CNIH4 
CNKSR1 
CNKSR2 
CNN3 
CNNM3 
CNOT1 
CNOT7 
CNP 
CNPY2 
CNR1 
CNST 
CNTF 
CNTFR 
CNTLN 
CNTN1 
CNTN2 
CNTN3 
CNTNAP1 
CNTNAP2 
CNTNAP4 
CNTRL 
CNTROB 
COASY 
COBL 
COBLL1 
COG2 
COG3 
COG4 
COG5 
COG6 
COG7 
COIL 
COL17A1 
COL18A1 
COL1A2 
COL27A1 
COL4A3B
P 
COL4A5 
COL6A2 
COL7A1 
COL9A2 
COL9A3 
COLGALT
1 
COLQ 
COMMD
1 
COMMD
3-BMI1 
COMT 
COPA 
COPB1 
COPB2 
COPE 
COPG1 
COPG2 
COPRS 
COPS2 
COPS3 
COPS4 
COPS5 
COPS6 
COPS7A 
COPS7B 
COPS8 
COPZ1 
COQ10A 
COQ8A 
CORO1B 
CORO1C 
CORO2A 
CORO6 
CORO7 
COX1 
COX15 
COX5A 
COX5B 
COX6C 
CP 
CPA1 
CPE 
CPEB1 
CPEB3 
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CPEB4 
CPLX1 
CPLX2 
CPM 
CPN1 
CPNE1 
CPNE2 
CPNE7 
CPNE8 
CPOX 
CPSF6 
CPSF7 
CPT1A 
CPTP 
CPXCR1 
CRABP2 
CRADD 
CRAMP1 
CRB1 
CRB3 
CRCT1 
CREB1 
CREB3 
CREB3L1 
CREB3L4 
CREB5 
CREBBP 
CRELD1 
CRELD2 
CREM 
CRHR1 
CRIM1 
CRIP1 
CRIPT 
CRK 
CRKL 
CRMP1 
CRNKL1 
CRP 
CRTC1 
CRTC2 
CRTC3 
CRY1 
CRY2 
CRYAA 
CRYAB 
CRYBA1 
CRYBA2 
CRYBA4 
CRYBB2 
CRYGC 
CSAD 
CSE1L 
CSF1R 
CSF2RB 
CSK 
CSMD1 
CSMD2 
CSN2 
CSN3 
CSNK1A1 
CSNK1A1
L 
CSNK1D 
CSNK1E 
CSNK1G1 
CSNK1G2 
CSNK1G3 
CSNK2A1 
CSNK2A2 
CSNK2B 
CSPG5 
CSRNP1 
CSRNP2 
CSRNP3 
CSRP1 
CSRP2 
CSRP3 
CST2 
CST6 
CST9L 
CSTA 
CSTB 
CT55 
CTAG1A 
CTAGE1 
CTAGE5 
CTBP1 
CTBP2 
CTCFL 
CTGF 
CTHRC1 
CTLA4 
CTNNA1 
CTNNA2 
CTNNA3 
CTNNAL1 
CTNNB1 
CTNNBIP
1 
CTNNBL1 
CTNND1 
CTNND2 
CTPS1 
CTPS2 
CTR9 
CTSD 
CTSG 
CTSV 
CTTN 
CTTNBP2 
CTTNBP2
NL 
CTXN3 
CUEDC1 
CUL1 
CUL2 
CUL3 
CUL4A 
CUL4B 
CUL5 
CUL9 
CUTC 
CWC15 
CWC22 
CWC25 
CWC27 
CXADR 
CXCL1 
CXCL11 
CXCL2 
CXCL5 
CXCR2 
CXCR4 
CXXC1 
CYB561D
1 
CYB5B 
CYBRD1 
CYC1 
CYCS 
CYFIP1 
CYFIP2 
CYLC2 
CYLD 
CYP24A1 
CYP2E1 
CYP39A1 
CYP4F2 
CYP4F8 
CYSLTR2 
CYSRT1 
CYTH2 
DAAM1 
DAAM2 
DAB1 
DAB2 
DAB2IP 
DACT1 
DAD1 
DAG1 
DAGLA 
DALRD3 
DAP3 
DAPK1 
DAPK3 
DAPP1 
DAXX 
DAZAP2 
DBF4B 
DBH 
DBI 
DBN1 
DBNL 
DBR1 
DCAF11 
DCAF13 
DCAF7 
DCAKD 
DCBLD2 
DCD 
DCDC2 
DCLK1 
DCLK3 
DCP1A 
DCTD 
DCTN1 
DCTN2 
DCTN3 
DCTN4 
DCUN1D
1 
DCUN1D
5 
DDB1 
DDB2 
DDC 
DDIT4 
DDIT4L 
DDN 
DDO 
DDR1 
DDR2 
DDX1 
DDX11 
DDX17 
DDX20 
DDX21 
DDX24 
DDX27 
DDX31 
DDX39B 
DDX3X 
DDX4 
DDX41 
DDX42 
DDX47 
DDX49 
DDX5 
DDX55 
DDX6 
DDX60L 
DEAF1 
DECR1 
DEFA1 
DEFB124 
DENND1
A 
DENND2
A 
DENND4
A 
DENND4
C 
DEPDC1B 
DERL2 
DES 
DEUP1 
DFFA 
DFFB 
DFNA5 
DGAT1 
DGAT2L6 
DGCR6L 
DGCR8 
DGKA 
DGKE 
DGKG 
DGKH 
DGKI 
DGKZ 
DHCR24 
DHCR7 
DHRS11 
DHRS2 
DHX15 
DHX16 
DHX30 
DHX34 
DHX36 
DHX9 
DIAPH1 
DIAPH2 
DIAPH3 
DIDO1 
DIEXF 
DIRAS2 
DIS3 
DISC1 
DISP3 
DIXDC1 
DKC1 
DKFZp45
1B226 
DKFZp68
6J1593 
DKK1 
DKKL1 
DLG1 
DLG2 
DLG3 
DLG4 
DLG5 
DLGAP1 
DLGAP2 
DLGAP3 
DLGAP4 
DLK1 
DLK2 
DLST 
DLX4 
DMBX1 
DMC1 
DMD 
DMKN 
DMRT1 
DMRT3 
DMTN 
DMWD 
DMXL2 
DNAAF2 
DNAAF5 
DNAH1 
DNAH3 
DNAH7 
DNAJA1 
DNAJA2 
DNAJA3 
DNAJB1 
DNAJB11 
DNAJB12 
DNAJB13 
DNAJB4 
DNAJB5 
DNAJB6 
DNAJC10 
DNAJC11 
DNAJC13 
DNAJC21 
DNAJC3 
DNAJC4 
DNAJC5 
DNAJC6 
DNAJC7 
DNAJC8 
DNAL4 
DNALI1 
DNASE1L
2 
DNM1 
DNM1L 
DNM2 
DNM3 
DNMBP 
DNMT1 
DNMT3B 
DNMT3L 
DNPEP 
DNTTIP1 
DNTTIP2 
DOC2B 
DOCK1 
DOCK10 
DOCK2 
DOCK3 
DOCK6 
DOCK7 
DOCK8 
DOCK9 
DOK1 
DOK4 
DOK5 
DOK6 
DOK7 
DOLK 
DOT1L 
DPCD 
DPCR1 
DPF2 
DPM1 
DPM3 
DPP3 
DPP4 
DPP7 
DPP9 
DPPA2 
DPPA4 
DPY30 
DPYD 
DPYSL2 
DPYSL3 
DPYSL4 
DPYSL5 
DQX1 
DR1 
DRAP1 
DRD2 
DRD4 
DRG1 
DROSHA 
DRP2 
DSCAML1 
DSG2 
DSN1 
DSP 
DST 
DSTN 
DTNA 
DTNB 
DTNBP1 
DTX1 
DTX2 
DTX3 
DTX3L 
DUPD1 
DUSP12 
DUSP15 
DUSP16 
DUSP18 
DUSP26 
DUSP3 
DUSP9 
DUX1 
DUX3 
DUX4 
DUX4L9 
DVL1 
DVL2 
DVL3 
DYNC1H1 
DYNC1I1 
DYNC1I2 
DYNC1LI2 
DYNLL1 
DYNLL2 
DYNLRB1 
DYRK1A 
DYRK1B 
DYRK3 
DYRK4 
DYSF 
DYX1C1 
DZIP3 
E2F3 
E2F8 
EAF1 
EBLN2 
ECD 
ECHDC1 
ECHS1 
ECM1 
ECM29 
ECSIT 
ECT2 
EDARAD
D 
EDC3 
EDRF1 
EEA1 
EEF1A1 
EEF1A2 
EEF1B2 
EEF1D 
EEF1E1 
EEF1G 
EEF2 
EEF2K 
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EEF2KMT 
EFEMP1 
EFEMP2 
EFHC1 
EFHC2 
EFHD1 
EFHD2 
EFNA2 
EFNA4 
EFNA5 
EFNB1 
EFNB2 
EFNB3 
EFS 
EFTUD2 
EGF 
EGFL6 
EGFR 
EGLN3 
EGR1 
EHBP1 
EHD1 
EHD2 
EHD3 
EHD4 
EHHADH 
EHMT2 
EID2B 
EIF1 
EIF1AD 
EIF1B 
EIF2AK2 
EIF2AK4 
EIF2B1 
EIF2B2 
EIF2B3 
EIF2B4 
EIF2B5 
EIF2S1 
EIF3A 
EIF3B 
EIF3D 
EIF3E 
EIF3F 
EIF3G 
EIF3H 
EIF3I 
EIF3J 
EIF3K 
EIF3L 
EIF3S3 
EIF4A3 
EIF4B 
EIF4E 
EIF4E2 
EIF4EBP1 
EIF4G1 
EIF4G2 
EIF4H 
EIF5 
EIF5A 
EIF5B 
EIF6 
EIPR1 
ELAVL1 
ELF3 
ELF5 
ELFN1 
ELFN2 
ELK1 
ELL 
ELL2 
ELMO1 
ELMSAN1 
ELOA 
ELOB 
ELOC 
ELOVL7 
EMD 
EMILIN1 
EML4 
ENAH 
ENG 
ENGASE 
ENKD1 
ENKUR 
ENO1 
ENO1B 
ENO2 
ENO3 
ENOX1 
ENPP1 
ENPP2 
ENPP3 
ENSA 
ENTPD6 
ENY2 
EOGT 
EP300 
EP400 
EPAS1 
EPB41 
EPB41L1 
EPB41L2 
EPB41L3 
EPB41L4
B 
EPB41L5 
EPHA10 
EPHA2 
EPHA3 
EPHA4 
EPHA7 
EPHA8 
EPHB4 
EPM2AIP
1 
EPN2 
EPOR 
EPRS 
EPS15 
EPS15L1 
EPS8 
EPS8L2 
EPSTI1 
ERBB2 
ERBB3 
ERBB4 
ERBIN 
ERC1 
ERC2 
ERCC1 
ERCC2 
ERCC3 
ERCC4 
ERCC6L 
ERCC8 
ERG 
ERGIC1 
ERH 
ERI1 
ERI3 
ERICH3 
ERLIN1 
ERLIN2 
ERMN 
ERP44 
ERRFI1 
ESCO2 
ESF1 
ESR1 
ESR2 
ESRRA 
ESRRG 
ESX1 
ESYT1 
ESYT2 
ETFA 
ETHE1 
ETNK2 
ETS1 
ETV5 
EVA1A 
EVC2 
EVI5L 
EVL 
EWSR1 
EXO1 
EXOC1 
EXOC2 
EXOC3 
EXOC4 
EXOC5 
EXOC6 
EXOC6B 
EXOC7 
EXOC8 
EXOSC10 
EXOSC5 
EXOSC8 
EXOSC9 
EXT2 
EXTL3 
EYA3 
EYA4 
EZH2 
EZR 
F11R 
F13A1 
F2R 
F2RL1 
F2RL2 
FA2H 
FAAH 
FAAP24 
FABP3 
FABP5 
FADD 
FADS6 
FAF1 
FAF2 
FAH 
FAHD1 
FAIM2 
FAM102A 
FAM103A
1 
FAM107A 
FAM110A 
FAM110B 
FAM110C 
FAM111B 
FAM114A
1 
FAM114A
2 
FAM118B 
FAM120C 
FAM122C 
FAM124B 
FAM127A 
FAM129A 
FAM131C 
FAM134B 
FAM135B 
FAM160A
2 
FAM161A 
FAM161B 
FAM162A 
FAM163A 
FAM163B 
FAM168A 
FAM168B 
FAM171A
1 
FAM171A
2 
FAM171B 
FAM173A 
FAM188A 
FAM189B 
FAM192A 
FAM207A 
FAM208A 
FAM208B 
FAM20C 
FAM213B 
FAM214B 
FAM218A 
FAM219B 
FAM22F 
FAM234A 
FAM27E3 
FAM3C 
FAM46B 
FAM47A 
FAM47B 
FAM49B 
FAM50B 
FAM53C 
FAM64A 
FAM65A 
FAM65B 
FAM65C 
FAM71C 
FAM71F1 
FAM74A4 
FAM81B 
FAM83A 
FAM83B 
FAM83D 
FAM83F 
FAM83H 
FAM86C1 
FAM90A1 
FAM98A 
FAM9A 
FAM9B 
FANCA 
FANCC 
FANCD2 
FANCF 
FANCI 
FANCL 
FAP 
FARP1 
FARS2 
FARSA 
FAS 
FASLG 
FASN 
FASTKD3 
FASTKD5 
FAT1 
FATE1 
FAXDC2 
FBF1 
FBL 
FBLIM1 
FBLN1 
FBN3 
FBP1 
FBP2 
FBXL15 
FBXL18 
FBXL3 
FBXL8 
FBXO11 
FBXO17 
FBXO18 
FBXO2 
FBXO21 
FBXO22 
FBXO28 
FBXO41 
FBXO45 
FBXO46 
FBXO7 
FBXO8 
FBXW11 
FBXW5 
FBXW7 
FCF1 
FCGR2B 
FCGR2C 
FCHO1 
FCHO2 
FCHSD1 
FCHSD2 
FCRL2 
FECH 
FEM1B 
FEN1 
FER 
FERMT2 
FERMT3 
FES 
FEZ1 
FEZ2 
FGD5 
FGD6 
FGF1 
FGF10 
FGF12 
FGF13 
FGF16 
FGF2 
FGF23 
FGF5 
FGF8 
FGFR1 
FGFR1OP 
FGFR1OP
2 
FGFR2 
FGR 
FHIT 
FHL1 
FHL2 
FHL3 
FHL5 
FHOD1 
FIBP 
FIP1L1 
FIS1 
FKBP14 
FKBP15 
FKBP1A 
FKBP1B 
FKBP3 
FKBP4 
FKBP5 
FKBP6 
FKBP7 
FKBP8 
FKBP9 
FKBPL 
FKSG66 
FKSG83 
FLAD1 
FLG2 
FLI1 
FLII 
FLJ13057 
FLJ34048 
FLNA 
FLNB 
FLNC 
FLOT1 
FLOT2 
FLRT1 
FLRT2 
FLRT3 
FLT1 
FLT3LG 
FLYWCH1 
FMNL1 
FMNL2 
FMNL3 
FMOD 
FMR1 
FN1 
FNBP1 
FNDC3A 
FNDC3B 
FOLH1 
FOPNL 
FOS 
FOSB 
FOSL1 
FOSL2 
FOXA3 
FOXB1 
FOXC1 
FOXD4 
FOXD4L6 
FOXE1 
FOXF2 
FOXG1 
FOXH1 
FOXI2 
FOXJ2 
FOXK1 
FOXK2 
FOXL1 
FOXM1 
FOXO1 
FOXO3 
FOXP1 
FOXP2 
FOXP3 
FOXQ1 
FOXS1 
FRAS1 
FRAT1 
FRAT2 
FRK 
FRMD5 
FRMD6 
FRMPD4 
FRYL 
FSBP 
FSCN1 
FSD2 
FTH1 
FTL 
FTSJ1 
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FUBP3 
FUCA2 
FUNDC1 
FUNDC2 
FUS 
FUT2 
FUT9 
FXN 
FXR1 
FXR2 
FXYD6 
FYB 
FYCO1 
FYN 
FZD2 
FZD3 
FZD5 
FZD6 
FZD7 
FZD8 
G2XKQ0 
G3BP1 
G3BP2 
GAB1 
GAB2 
GAB3 
GABARAP 
GABARAP
L1 
GABARAP
L2 
GABBR1 
GABBR2 
GABPB1 
GABPB2 
GABRA1 
GABRA2 
GABRA3 
GABRA4 
GABRA6 
GABRB1 
GABRB2 
GABRB3 
GABRD 
GABRQ 
GABRR1 
GAD1 
GAD2 
GADD45
A 
GADD45
G 
GADD45
GIP1 
GAK 
GALC 
GALNT10 
GALNT12 
GALNT2 
GALNT3 
GALNT7 
GAN 
GANAB 
GAP43 
GAPDH 
GAPDHS 
GAR1 
GAREM1 
GAS2L2 
GAS2L3 
GAS7 
GAS8 
GATA1 
GATA2 
GATA3 
GATAD2A 
GATAD2B 
GBA 
GBAS 
GBE1 
GBF1 
GBP2 
GCA 
GCAT 
GCC1 
GCDH 
GCFC2 
GCH1 
GCLM 
GCM2 
GCN1 
GCNT3 
GDA 
GDF5 
GDF9 
GDI1 
GDI2 
GEM 
GEMIN4 
GEMIN7 
GEMIN8 
GET4 
GFAP 
GFER 
GFI1 
GFI1B 
GFM2 
GGA1 
GGA2 
GGA3 
GGCT 
GGN 
GGT6 
GH1 
GHDC 
GHITM 
GHRH 
GHRL 
GID8 
GIGYF1 
GIGYF2 
GIMAP1 
GIMAP1-
GIMAP5 
GIMAP5 
GIMAP8 
GIPC1 
GIPC2 
GIT1 
GIT2 
GJA1 
GJA4 
GJA5 
GJB5 
GKAP1 
GLB1L2 
GLCE 
GLI1 
GLIPR1L2 
GLIS2 
GLOD4 
GLP1R 
GLP2R 
GLRA1 
GLRA2 
GLRB 
GLRX3 
GLS2 
GLT8D1 
GLTSCR1 
GLTSCR1L 
GLTSCR2 
GLUD1 
GLUL 
GLYAT 
GLYCTK 
GLYR1 
GMCL1P1 
GMEB2 
GNA13 
GNAI1 
GNAI2 
GNAI3 
GNAO1 
GNAQ 
GNAS 
GNB1 
GNB2 
GNB4 
GNB5 
GNE 
GNG12 
GNG3 
GNG4 
GNL2 
GNL3 
GNL3L 
GNMT 
GNPTAB 
GNS 
GOLGA1 
GOLGA2 
GOLGA4 
GOLGA5 
GOLGA6
A 
GOLGA6L
9 
GOLGA7 
GOLGA8
DP 
GOLGA8F 
GOLGB1 
GOLIM4 
GOLM1 
GOLPH3L 
GOLT1B 
GOPC 
GORAB 
GORASP2 
GOSR1 
GOSR2 
GOT1 
GOT2 
GP6 
GPAA1 
GPALPP1 
GPANK1 
GPATCH1
1 
GPATCH2 
GPATCH8 
GPBP1 
GPBP1L1 
GPC4 
GPD1 
GPER1 
GPHN 
GPKOW 
GPM6A 
GPM6B 
GPR108 
GPR12 
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ZNF286A 
ZNF3 
ZNF317 
ZNF319 
ZNF326 
ZNF329 
ZNF330 
ZNF333 
ZNF33B 
ZNF341 
ZNF35 
ZNF362 
ZNF365 
ZNF366 
ZNF385C 
ZNF408 
ZNF410 
ZNF414 
ZNF417 
ZNF438 
ZNF440 
ZNF446 
ZNF451 
ZNF462 
ZNF479 
ZNF488 
ZNF490 
ZNF496 
ZNF497 
ZNF509 
ZNF510 
ZNF512B 
ZNF518A 
ZNF524 
ZNF526 
ZNF532 
ZNF544 
ZNF563 
ZNF564 
ZNF568 
ZNF572 
ZNF575 
ZNF576 
ZNF579 
ZNF580 
ZNF581 
ZNF587 
ZNF592 
ZNF593 
ZNF597 
ZNF599 
ZNF622 
ZNF624 
ZNF638 
ZNF639 
ZNF648 
ZNF658B 
ZNF669 
ZNF670 
ZNF687 
ZNF691 
ZNF696 
ZNF697 
ZNF707 
ZNF71 
ZNF740 
ZNF746 
ZNF750 
ZNF76 
ZNF764 
ZNF765 
ZNF766 
ZNF768 
ZNF77 
ZNF774 
ZNF784 
ZNF785 
ZNF792 
ZNF827 
ZNF830 
ZNF837 
ZNF844 
ZNF91 
ZNFX1 
ZNHIT3 
ZNHIT6 
ZNRD1 
ZNRF1 
ZNRF2 
ZP2 
ZRANB1 
ZRANB2 
ZSCAN1 
ZSCAN12 
ZSCAN21 
ZSCAN23 
ZSCAN26 
ZSCAN30 
ZSCAN9 
ZSWIM1 
ZSWIM3 
ZSWIM6 
ZWINT 
ZXDC 
ZYX 
ZZZ3 
 
 
 
 
 
 
